Professor Jerry Greenfield

Professor Jerry Greenfield

Professor

MBBS (BSc Med), PhD, FRACP

Medicine & Health
School of Clinical Medicine

Professor Greenfield is an Endocrinologist and Clinical researcher. He is Head of Department, Endocrinology and Director, Diabetes Services, at St Vincent’s Hospital; Head, St Vincent's Clinical Campus and Professor of Medicine, University of New South Wales.

Professor Greenfield is Editorial Board member, Clinical Obesity and an Executive Council Member, Australian Diabetes Society.

He previously held an NHMRC Neil Hamilton Fairley Postdoctoral Research Fellowship, which allowed him to study in the Departments of Medicine and Clinical Biochemistry, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK (2005-6, Supervisors: Prof Stephen O’Rahilly and Dr Sadaf Farooqi). He undertook a PhD at the Garvan Institute from 2001-2004, under the supervision of Prof D Chisholm, Prof L Campbell and Prof K Samaras). He graduated from the Faculty of Medicine with Honours (class 1) from the University of NSW in 1995.

Phone
02 8382 2622
Location
Garvan Institute of Medical Research 384 Victoria Street DARLINGHURST NSW 2010
  • Book Chapters | 2015
    Greenfield JR; Samocha-Bonet D, 2015, 'Glutamine and glucagon-like peptide-1 response', in Rajendram R; Preedy VR; Patel VB (ed.), Glutamine in Clinical Nutrition, Springer, London
  • Journal articles | 2024
    Brzozowska MM; Bliuc D; Mazur A; Baldock PA; Eisman JA; Greenfield JR; Center JR, 2024, 'Correction: Sex-differential testosterone response to long-term weight loss (International Journal of Obesity, (2024), 10.1038/s41366-024-01591-7)', International Journal of Obesity, 48, pp. 1514, http://dx.doi.org/10.1038/s41366-024-01597-1
    Journal articles | 2024
    Brzozowska MM; Bliuc D; Mazur A; Baldock PA; Eisman JA; Greenfield JR; Center JR, 2024, 'Sex-differential testosterone response to long-term weight loss', International Journal of Obesity, 48, pp. 1481 - 1488, http://dx.doi.org/10.1038/s41366-024-01591-7
    Journal articles | 2024
    FRAMPTON R; SNAITH JR; HOCKING SL; GREENFIELD J, 2024, '787-P: Reducing Cardiometabolic Risk with Semaglutide in Type 1 Diabetes (RESET1)—A Double-Blinded Randomized Placebo-Controlled Trial (Study Protocol)', Diabetes, 73, http://dx.doi.org/10.2337/db24-787-p
    Journal articles | 2024
    Forner P; Snaith J; Greenfield JR, 2024, 'Prescribing patterns of adjunctive therapy for the treatment of type 1 diabetes mellitus among Australian endocrinologists', Internal Medicine Journal, 54, pp. 779 - 785, http://dx.doi.org/10.1111/imj.16312
    Journal articles | 2024
    Frampton R; Snaith JR; Hocking S; Holmes-Walker J; Olsen N; Greenfield JR, 2024, 'Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial', Diabetic Medicine, 41, http://dx.doi.org/10.1111/dme.15377
    Journal articles | 2024
    Hayes AG; Penny MJ; Aivazian K; Greenfield JR, 2024, 'Acute Interstitial Nephritis and Oxalate Nephropathy After Rapid Pasireotide Response in Treatment-resistant Acromegaly.', JCEM Case Rep, 2, pp. luae071, http://dx.doi.org/10.1210/jcemcr/luae071
    Journal articles | 2024
    JANUSZEWSKI AS; SNAITH JR; KOWALSKI GM; BRUCE C; HOLMES-WALKER J; JENKINS A; GREENFIELD J, 2024, '1607-P: Estimation of Muscle and Hepatic Insulin Sensitivity in Type 1 Diabetes Adults Using Clinical and Research Biomarkers', Diabetes, 73, http://dx.doi.org/10.2337/db24-1607-p
    Journal articles | 2024
    Jeyakumar S; Jeyakumar R; Robson D; Honeysett L; Raven L; Campos Deveza e Silva R; Jabbour A; Kotlyar E; Keogh A; Greenfield J; MacDonald P; Hayward C; Muthiah K, 2024, 'Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in End-Stage Heart Failure Patients Considered for Heart Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S106 - S106, http://dx.doi.org/10.1016/j.healun.2024.02.213
    Journal articles | 2024
    Lamaro BD; Greenfield JR; Snaith JR, 2024, 'Can Unmet Needs Be Addressed by Adjunctive Therapies? Findings from a Patient Perspectives Survey in Adults with Type 1 Diabetes', Journal of Patient Experience, 11, http://dx.doi.org/10.1177/23743735241257811
    Journal articles | 2024
    Lasschuit JWJ; Center JR; Greenfield JR; Tonks KTT, 2024, 'Effect of denosumab on inflammation and bone health in active Charcot foot: A phase II randomised controlled trial', Journal of Diabetes and its Complications, 38, http://dx.doi.org/10.1016/j.jdiacomp.2024.108718
    Journal articles | 2024
    Milder TY; Lin J; Pearson SA; Greenfield JR; Day RO; Stocker SL; Neuen BL; Falster MO; de Oliveira Costa J, 2024, 'Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018–2022', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.16231
    Journal articles | 2024
    Milder TY; Lin J; Pearson SA; de Oliveira Costa J; Neuen BL; Pollock C; Jun M; Greenfield JR; Day RO; Stocker SL; Brieger D; Falster MO, 2024, 'Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?', Diabetes, Obesity and Metabolism, http://dx.doi.org/10.1111/dom.16061
    Journal articles | 2024
    Milder TY; Stocker SL; Baysari MT; Day RO; Greenfield JR, 2024, '‘We are somehow fixated on this being a diabetes drug’: a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiation', Internal Medicine Journal, 54, pp. 559 - 567, http://dx.doi.org/10.1111/imj.16203
    Journal articles | 2024
    Muir CA; Kuang W; Muthiah K; Greenfield JR; Raven LM, 2024, 'Association of early post-transplant hyperglycaemia and diabetes mellitus on outcomes following heart transplantation', Diabetic Medicine, http://dx.doi.org/10.1111/dme.15441
    Journal articles | 2024
    O'Donnell JEM; Hastings LA; Briody JN; Chan CL; Colombo C; Douglas TA; Freedman SD; Gonska T; Greenfield JR; Leung DH; Lim AYL; Moran A; Prentice BJ; Putman MS; Trotter M; Tullis E; Westall GP; Verge CF; Wainwright CE; Ooi CY; Engelhardt JF; Katz T; King S; Lewindon PJ; Matson AG; McDonald CM; Moheet A; Narkewicz MR; Oliver M; Ramm GA; Sellers ZM; Wilschanski M, 2024, 'SHIFTing goals in cystic fibrosis—managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium', Pediatric Pulmonology, 59, pp. 1661 - 1676, http://dx.doi.org/10.1002/ppul.26970
    Journal articles | 2024
    Patel SK; Fourlanos S; Greenfield JR, 2024, 'Atypical Diabetes: What Have We Learned and What Does the Future Hold? Diabetes Care 2024;47:770–781', Diabetes Care, 47, http://dx.doi.org/10.2337/dc24-1388
    Journal articles | 2024
    Patel SK; Fourlanos S; Greenfield JR, 2024, 'Classification of type 1 diabetes: A pathogenic and treatment-based classification', Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 18, http://dx.doi.org/10.1016/j.dsx.2024.102986
    Journal articles | 2024
    Raven LM; Brown C; Greenfield JR, 2024, 'Considerations of delayed gastric emptying with peri-operative use of glucagon-like peptide-1 receptor agonists', Medical Journal of Australia, 220, pp. 14 - 16, http://dx.doi.org/10.5694/mja2.52170
    Journal articles | 2024
    Raven LM; Cao JY; Macdonald PS; Jabbour A; Greenfield JR, 2024, 'Fournier’s gangrene in recent transplant recipient on empagliflozin', JHLT Open, 4, pp. 100060 - 100060, http://dx.doi.org/10.1016/j.jhlto.2024.100060
    Journal articles | 2024
    Raven LM; Muir CA; Deveza RC; Kessler Iglesias C; Bart NK; Muthiah K; Kotlyar E; Hayward CS; Macdonald PS; Jabbour A; Greenfield JR, 2024, 'Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation', JHLT Open, 5, pp. 100088 - 100088, http://dx.doi.org/10.1016/j.jhlto.2024.100088
    Journal articles | 2024
    Raven LM; Muir CA; Kessler Iglesias C; Bart NK; Muthiah K; Kotlyar E; Hayward CS; Macdonald PS; Jabbour A; Greenfield JR, 2024, 'Safety of Sodium Glucose Co-Transporter 2 Inhibitor Exposure Prior to Heart Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S148 - S149, http://dx.doi.org/10.1016/j.healun.2024.02.302
    Journal articles | 2024
    SNAITH JR; OLSEN ND; KOWALSKI GM; BRUCE C; EVANS JL; JANUSZEWSKI AS; JENKINS A; BREIT SN; HOLMES-WALKER J; GREENFIELD J, 2024, '865-P: Metformin Reduces Insulin Dose and Visceral Fat Accumulation, and Increases GDF15 without Reducing Insulin Resistance in Adults with Type 1 Diabetes—A 26-Week, Randomized, Double-Blind Placebo-Controlled Trial (INTIMET)', Diabetes, 73, http://dx.doi.org/10.2337/db24-865-p
    Journal articles | 2024
    Shen I; Stojanova J; Yeo M; Olsen N; Lockart I; Wang M; Roggeveld J; Heerspink HJL; Greenfield JR; Day R; Danta M, 2024, 'A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease', British Journal of Clinical Pharmacology, 90, pp. 2529 - 2538, http://dx.doi.org/10.1111/bcp.16139
    Journal articles | 2024
    Sriravindrarajah A; Hurwitz J; Lim E; Greenfield JR, 2024, 'Hyperglycemia secondary to phosphatidylinositol-3 kinase (PI3K) inhibition', Endocrinology, Diabetes and Metabolism Case Reports, 2024-October, http://dx.doi.org/10.1530/EDM-24-0040
    Journal articles | 2024
    de Oliveira Costa J; Lin J; Milder TY; Greenfield JR; Day RO; Stocker SL; Neuen BL; Havard A; Pearson SA; Falster MO, 2024, 'Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia', Diabetes, Obesity and Metabolism, 26, pp. 2787 - 2795, http://dx.doi.org/10.1111/dom.15597
    Journal articles | 2023
    Brzozowska MM; Isaacs M; Bliuc D; Baldock PA; Eisman JA; White CP; Greenfield JR; Center JR, 2023, 'Effects of bariatric surgery and dietary intervention on insulin resistance and appetite hormones over a 3 year period', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-33317-6
    Journal articles | 2023
    Chavali S; Barua S; Adji A; Robson D; Raven LM; Greenfield JR; Eckford H; Macdonald PS; Hayward CS; Muthiah K, 2023, 'Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices', International Journal of Cardiology, 391, http://dx.doi.org/10.1016/j.ijcard.2023.131259
    Journal articles | 2023
    Chavali S; Barua S; Adjii A; Robson D; Raven L; Greenfield J; Parvar S; MacDonald P; Hayward C; Muthiah K, 2023, 'Safety and Tolerability of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients Supported with Left Ventricular Assist Devices', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 42, pp. S450 - S451, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480601267&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2023
    Chowdhury G; Carland JE; Kumar S; Olsen N; Graham G; Kumarasinghe G; Hayward CS; Greenfield JR; Macdonald P; Day RO; Stocker SL, 2023, 'The safe use of metformin in heart failure patients both with and without T2DM: A cross-sectional and longitudinal study', British Journal of Clinical Pharmacology, 89, pp. 2603 - 2613, http://dx.doi.org/10.1111/bcp.15737
    Journal articles | 2023
    Cooper B; Blaker K; Greenfield JR, 2023, 'Olanzapine-induced multifactorial chylomicronaemia syndrome: a rare but important complication', ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2023, http://dx.doi.org/10.1530/EDM-22-0225
    Journal articles | 2023
    Hayes AG; Raven LM; Viardot A; Kotlyar E; Greenfield JR, 2023, 'SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes', Diabetes Care, 47, pp. e4 - e5, http://dx.doi.org/10.2337/dc23-1903
    Journal articles | 2023
    Lasschuit JWJ; Greenfield JR; Tonks KTT, 2023, 'Response to the Letter to the Editor regarding “Contribution of peripheral neuropathy to poor bone health in the feet of people with type 2 diabetes mellitus”', Acta Diabetologica, 60, pp. 713 - 714, http://dx.doi.org/10.1007/s00592-023-02052-9
    Journal articles | 2023
    Lin J; Pearson SA; Greenfield JR; Park KH; Havard A; Brieger D; Day RO; Falster MO; de Oliveira Costa J, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)', European Journal of Clinical Pharmacology, 79, pp. 1239 - 1248, http://dx.doi.org/10.1007/s00228-023-03539-8
    Journal articles | 2023
    Milder TY; Greenfield JR; Milder DA, 2023, 'Peri-procedural ketoacidosis risk with sodium-glucose cotransporter 2 inhibitor use in people without diabetes', Anaesthesia, 78, pp. 1418 - 1419, http://dx.doi.org/10.1111/anae.16068
    Journal articles | 2023
    Milder TY; Milder DA; Greenfield JR; Day RO, 2023, 'Sodium-Glucose Cotransporter 2 Inhibitor-Associated “Ketoacidosis” Versus “Diabetic Ketoacidosis”: The Importance of Accurate Terminology', Drug Safety, 46, pp. 1303 - 1305, http://dx.doi.org/10.1007/s40264-023-01358-5
    Journal articles | 2023
    RAVEN LM; MUIR CA; POULIOPOULOS JIM; MACDONALD PS; JABBOUR A; GREENFIELD J, 2023, '1438-P: Diabetes after Cardiac Transplant with Low-Dose Everolimus and Tacrolimus', Diabetes, 72, http://dx.doi.org/10.2337/db23-1438-p
    Journal articles | 2023
    Raven LM; Greenfield JR; Muir CA, 2023, 'Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes.', JCEM Case Rep, 1, pp. luac017, http://dx.doi.org/10.1210/jcemcr/luac017
    Journal articles | 2023
    Raven LM; Muir CA; Greenfield JR, 2023, 'Sodium glucose cotransporter 2 inhibitor-induced ketoacidosis is unlikely in patients without diabetes', Medical Journal of Australia, 219, pp. 293 - 294, http://dx.doi.org/10.5694/mja2.52067
    Journal articles | 2023
    Raven LM; Muir CA; Kessler Iglesias C; Bart NK; Muthiah K; Kotlyar E; Macdonald P; Hayward CS; Jabbour A; Greenfield JR, 2023, 'Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): Protocol for a randomised controlled trial', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-069641
    Journal articles | 2023
    Raven LM; Muir CA; Kessler Iglesias C; Kotlyar E; Muthiah K; Bart NK; Macdonald PS; Hayward CS; Jabbour A; Greenfield JR, 2023, 'THU298 Effect Of SGLT2 Inhibition On Metabolic, Cardiac And Renal Outcomes In Heart Transplant Recipients (EMPA-HTx study): Protocol And Study Design', Journal of the Endocrine Society, 7, http://dx.doi.org/10.1210/jendso/bvad114.733
    Journal articles | 2023
    Raven LM; Muir CA; Macdonald PS; Hayward CS; Jabbour A; Greenfield JR, 2023, 'Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies—a joint review from endocrinologists and cardiologists', Acta Diabetologica, 60, pp. 471 - 480, http://dx.doi.org/10.1007/s00592-022-02018-3
    Journal articles | 2023
    Raven LM; Muir CA; Pouliopoulos J; Hayward CS; Macdonald PS; Greenfield JR; Jabbour A, 2023, 'Metabolic Sequelae of Everolimus Treatment After Cardiac Transplant: A Hypothesis-Generating Study', Heart Lung and Circulation, 32, pp. 1076 - 1079, http://dx.doi.org/10.1016/j.hlc.2023.05.014
    Journal articles | 2023
    Raven LM; Stoita A; Feller RB; Brown C; Greenfield JR, 2023, 'Delayed Gastric Emptying with Perioperative Use of Glucagon-like Peptide-1 Receptor Agonists', American Journal of Medicine, 136, pp. e233 - e234, http://dx.doi.org/10.1016/j.amjmed.2023.07.016
    Journal articles | 2023
    Sheu A; Blank RD; Tran T; Bliuc D; Greenfield JR; White CP; Center JR, 2023, 'Associations of Type 2 Diabetes, Body Composition, and Insulin Resistance with Bone Parameters: The Dubbo Osteoporosis Epidemiology Study', JBMR Plus, 7, http://dx.doi.org/10.1002/jbm4.10780
    Journal articles | 2023
    Sheu A; Greenfield JR; White CP; Center JR, 2023, 'Contributors to impaired bone health in type 2 diabetes', Trends in Endocrinology and Metabolism, 34, pp. 34 - 48, http://dx.doi.org/10.1016/j.tem.2022.11.003
    Journal articles | 2023
    Snaith JR; Greenfield JR; Malozowski S; Weghuber D; Kelly AS; Arslanian S, 2023, 'Once-Weekly Semaglutide in Adolescents with Obesity', New England Journal of Medicine, 388, pp. 1145, http://dx.doi.org/10.1056/NEJMc2300510
    Journal articles | 2023
    Snaith JR; Olsen N; Kowalski G; Bruce C; Holmes-Walker J; Greenfield JR, 2023, 'OR18-03 Peripheral But Not Hepatic Insulin Resistance Associates With Adverse Vascular And Metabolic Health In Type 1 Diabetes: A Possible Target For Adjunctive Therapy', Journal of the Endocrine Society, 7, http://dx.doi.org/10.1210/jendso/bvad114.895
    Journal articles | 2022
    Bennett MJ; Balcerek MI; Lewis EAD; Zhang RLL; Bachmeier C; Tey S; Faux S; Girgis L; Greenfield JR; Lazarus S; Bennett M, 2022, 'Voriconazole-Associated Periostitis: New Insights into Pathophysiology and Management', JBMR Plus, 6, pp. e10557, http://dx.doi.org/10.1002/jbm4.10557
    Journal articles | 2022
    Brzozowska M; Isaacs M; Bliuc D; Baldock P; Eisman J; White C; Greenfield J; Center J, 2022, 'Effects of bariatric surgery and dietary intervention on changes in insulin resistance and appetite hormones over the period of 3 years', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.81.rc5.6
    Journal articles | 2022
    Chavali S; Muthiah K; Hayward C; Macdonald P; Robson D; Greenfield J; Raven L, 2022, 'Safety and Tolerability of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients Supported With Left Ventricular Assist Devices', Heart, Lung and Circulation, 31, pp. S100 - S100, http://dx.doi.org/10.1016/j.hlc.2022.06.124
    Journal articles | 2022
    Dahiya S; Tisch S; Greenfield J, 2022, 'The effect of GLP-1 receptor agonists in pre-clinical rodent models of Parkinson's disease: A systematic review and meta-analysis', Clinical Parkinsonism and Related Disorders, 6, http://dx.doi.org/10.1016/j.prdoa.2022.100133
    Journal articles | 2022
    Koay YC; Coster ACF; Chen DL; Milner B; Batarseh A; O’Sullivan JF; Greenfield JR; Samocha-Bonet D, 2022, 'Metabolomics and Lipidomics Signatures of Insulin Resistance and Abdominal Fat Depots in People Living with Obesity', Metabolites, 12, pp. 1272, http://dx.doi.org/10.3390/metabo12121272
    Journal articles | 2022
    Lasschuit JWJ; Greenfield JR; Tonks KTT, 2022, 'Contribution of peripheral neuropathy to poor bone health in the feet of people with type 2 diabetes mellitus', Acta Diabetologica, 59, pp. 217 - 224, http://dx.doi.org/10.1007/s00592-021-01803-w
    Journal articles | 2022
    Milder T; Stocker S; Baysari M; Day R; Greenfield J, 2022, 'Prescribing of SGLT2 Inhibitors in Clinical Practice: A Qualitative Study of Cardiologists', Heart, Lung and Circulation, 31, pp. S96 - S97, http://dx.doi.org/10.1016/j.hlc.2022.06.117
    Journal articles | 2022
    Moxham R; Greenfield JR; Viardot A; Wu KHC, 2022, 'Tip of the iceberg: are we missing undiagnosed patients with maturity onset diabetes of the young?', Internal Medicine Journal, 52, pp. 2011 - 2012, http://dx.doi.org/10.1111/imj.15948
    Journal articles | 2022
    Patel SK; Ma CS; Bell KJ; Oram R; Hagopian WA; Fourlanos S; Greenfield JR, 2022, 'Immunophenotype and genetic risk scores to improve autoantibody negative type 1 diabetes classification: study protocol', International Journal of Clinical Trials, 9, pp. 293 - 293, http://dx.doi.org/10.18203/2349-3259.ijct20222690
    Journal articles | 2022
    Raven LM; Mccormack AI; Greenfield JR, 2022, 'Letter to the Editor From Raven et al: "Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine"', Journal of Clinical Endocrinology and Metabolism, 107, pp. E1767 - E1768, http://dx.doi.org/10.1210/clinem/dgab822
    Journal articles | 2022
    Raven LM; Morris P; Greenfield JR, 2022, 'Hyperglycaemia induced by gamma-butyrolactone', Diabetic Medicine, 39, http://dx.doi.org/10.1111/dme.14850
    Journal articles | 2022
    Sheu A; Greenfield JR; White CP; Center JR, 2022, 'Assessment and treatment of osteoporosis and fractures in type 2 diabetes', Trends in Endocrinology and Metabolism, 33, pp. 333 - 344, http://dx.doi.org/10.1016/j.tem.2022.02.006
    Journal articles | 2022
    Snaith JR; Greenfield JR, 2022, 'Sodium–glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?', Medical Journal of Australia, 217, pp. 126 - 128, http://dx.doi.org/10.5694/mja2.51637
    Journal articles | 2022
    Tiwary M; Milder TY; Stocker SL; Day RO; Greenfield JR, 2022, 'Sodium-glucose co-transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction', Internal Medicine Journal, 52, pp. 1666 - 1676, http://dx.doi.org/10.1111/imj.15727
    Journal articles | 2021
    Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR, 2021, 'Plasma Bile Acids More Closely Align with Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity', Journal of Clinical Endocrinology and Metabolism, 106, pp. E1131 - E1139, http://dx.doi.org/10.1210/clinem/dgaa940
    Journal articles | 2021
    Heidegger DP; Neal KE; Patel SK; Greenfield JR; Tonks KT, 2021, 'Effect of fasting ketosis and type 1 diabetes on alcohol breath analysis technology used in Australia', Internal Medicine Journal, 51, pp. 1555 - 1556, http://dx.doi.org/10.1111/imj.15488
    Journal articles | 2021
    Milder T; Stocker S; Baysari M; Day RO; Greenfield J, 2021, 'Prescribing of SGLT2 Inhibitors in Primary Care: A Qualitative Study of Primary Care Physicians and Endocrinologists', DIABETES, 70, http://dx.doi.org/10.2337/db21-779-P
    Journal articles | 2021
    Milder TY; Stocker SL; Baysari M; Day RO; Greenfield JR, 2021, 'Prescribing of SGLT2 inhibitors in primary care: A qualitative study of General Practitioners and Endocrinologists', Diabetes Research and Clinical Practice, 180, http://dx.doi.org/10.1016/j.diabres.2021.109036
    Journal articles | 2021
    Patel SK; Fourlanos S; Greenfield JR, 2021, 'Comment on ‘impact of routine Clinic Measurement of random Serum c-peptide in people with a Clinician Diagnosis of type 1 diabetes’', Diabetic Medicine, 38, http://dx.doi.org/10.1111/dme.14513
    Journal articles | 2021
    Patel SK; Ma CS; Fourlanos S; Greenfield JR, 2021, 'Autoantibody-Negative Type 1 Diabetes: A Neglected Subtype', Trends in Endocrinology and Metabolism, 32, pp. 295 - 305, http://dx.doi.org/10.1016/j.tem.2021.02.001
    Journal articles | 2021
    Perera CJ; Falasca M; Chari ST; Greenfield JR; Xu Z; Pirola RC; Wilson JS; Apte MV, 2021, 'Role of pancreatic stellate cell-derived exosomes in pancreatic cancer-related diabetes: A novel hypothesis', Cancers, 13, pp. 5224, http://dx.doi.org/10.3390/cancers13205224
    Journal articles | 2021
    Snaith JR; Danta M; Greenfield JR, 2021, 'Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes', The Lancet Gastroenterology and Hepatology, 6, pp. 985 - 986, http://dx.doi.org/10.1016/S2468-1253(21)00343-5
    Journal articles | 2021
    Snaith JR; Samocha-Bonet D; Evans J; Liu Z; Kowalski G; Bruce C; Holmes-Walker DJ; Greenfield JR, 2021, 'Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial', Diabetic Medicine, 38, http://dx.doi.org/10.1111/dme.14564
    Journal articles | 2021
    Watt KI; Henstridge DC; Ziemann M; Sim CB; Montgomery MK; Samocha-Bonet D; Parker BL; Dodd GT; Bond ST; Salmi TM; Lee RS; Thomson RE; Hagg A; Davey JR; Qian H; Koopman R; El-Osta A; Greenfield JR; Watt MJ; Febbraio MA; Drew BG; Cox AG; Porrello ER; Harvey KF; Gregorevic P, 2021, 'Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease', Nature Communications, 12, http://dx.doi.org/10.1038/s41467-021-23240-7
    Journal articles | 2020
    Harari A; Coster ACF; Jenkins A; Xu A; Greenfield JR; Harats D; Shaish A; Samocha-Bonet D, 2020, 'Obesity and Insulin Resistance Are Inversely Associated with Serum and Adipose Tissue Carotenoid Concentrations in Adults', Journal of Nutrition, 150, pp. 38 - 46, http://dx.doi.org/10.1093/jn/nxz184
    Journal articles | 2020
    Htet TD; Godneva A; Liu Z; Chalmers E; Kolobkov D; Snaith JR; Richens R; Toth K; Danta M; Hng TM; Elinav E; Segal E; Greenfield JR; Samocha-Bonet D, 2020, 'Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin', BMJ Open, 10, pp. e037859, http://dx.doi.org/10.1136/bmjopen-2020-037859
    Journal articles | 2020
    Hussain I; Jin RR; Baum HBA; Greenfield JR; Devery S; Xing C; Hegele RA; Carranza-Leon BG; Linton MF; Vuitch F; Wu KHC; Precioso DR; Oshima J; Agarwal AK; Garg A, 2020, 'Multisystem progeroid syndrome with lipodystrophy, cardiomyopathy, and nephropathy due to an LMNA p.R349W variant', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa104
    Journal articles | 2020
    Lasschuit JWJ; Center JR; Greenfield JR; Tonks KTT, 2020, 'Comparison of calcaneal quantitative ultrasound and bone densitometry parameters as fracture risk predictors in type 2 diabetes mellitus', Diabetic Medicine, 37, pp. 1902 - 1909, http://dx.doi.org/10.1111/dme.14183
    Journal articles | 2020
    Lasschuit JWJ; Greenfield JR; Tonks KT, 2020, 'High Risk Foot Service reduces number of Emergency Department presentations and length of stay', Diabetes and Metabolism, 46, pp. 252 - 255, http://dx.doi.org/10.1016/j.diabet.2018.07.002
    Journal articles | 2020
    Martin C; Ait Boudaoud A; Poghosyan T; Zhu J; Larger E; Greenfield JR; Czernichow S; Rives-Lange C; Carette C, 2020, 'Prevalence of anti-GAD and IA2 autoantibodies in a French cohort of patients with diabetes eligible for bariatric surgery', Diabetes and Metabolism, 46, pp. 407 - 409, http://dx.doi.org/10.1016/j.diabet.2019.12.004
    Journal articles | 2020
    Milder TY; Day RO; Stocker SL; Greenfield JR, 2020, 'Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetes', Internal Medicine Journal, 50, pp. 645 - 646, http://dx.doi.org/10.1111/imj.14819
    Journal articles | 2020
    Milder TY; Stocker SL; Day RO; Greenfield JR, 2020, 'Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease', Drug Safety, 43, pp. 1211 - 1221, http://dx.doi.org/10.1007/s40264-020-01010-6
    Journal articles | 2020
    Mortimer B; Naganur VD; Satouris P; Greenfield JR; Torpy DJ; Rushworth RL, 2020, 'Acute illness in patients with concomitant Addison's disease and type 1 diabetes mellitus: Increased incidence of hypoglycaemia and adrenal crises', Clinical Endocrinology, 93, pp. 104 - 110, http://dx.doi.org/10.1111/cen.14219
    Journal articles | 2020
    Muir CA; Greenfield JR; Weissberger A; Jones GRD; Samaras K, 2020, 'SAT-LB75 Thyroid Peroxidase Antibody Positivity Predicts Relapse Free Survival Following Anti-Thyroid Drug Treatment for Graves Disease', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.2016
    Journal articles | 2020
    Muir CA; Jones GRD; Greenfield JR; Weissberger A; Samaras K, 2020, 'THYROID PEROXIDASE ANTIBODY POSITIVITY IS ASSOCIATED with RELAPSE-FREE SURVIVAL following ANTITHYROID DRUG TREATMENT for GRAVES DISEASE', Endocrine Practice, 26, pp. 1026 - 1030, http://dx.doi.org/10.4158/EP-2020-0035
    Journal articles | 2020
    Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte MV, 2020, '1133 PANCREATIC STELLATE CELL AND CANCER CELL DERIVED EXOSOMES IMPAIR BETA CELL FUNCTION: IMPLICATIONS FOR PANCREATIC CANCER RELATED DIABETES.', Gastroenterology, 158, pp. S - 221, http://dx.doi.org/10.1016/s0016-5085(20)31245-2
    Journal articles | 2020
    Smith FC; Stocker SL; Danta M; Carland JE; Kumar SS; Liu Z; Greenfield JR; Braithwaite HE; Cheng TS; Graham GG; Williams KM; Day RO, 2020, 'The safety and pharmacokinetics of metformin in patients with chronic liver disease', Alimentary Pharmacology and Therapeutics, 51, pp. 565 - 575, http://dx.doi.org/10.1111/apt.15635
    Journal articles | 2020
    Snaith JR; Greenfield JR, 2020, 'COVID-19: it's changed us', Internal Medicine Journal, 50, pp. 1162 - 1163, http://dx.doi.org/10.1111/imj.14968
    Journal articles | 2020
    Snaith JR; Holmes-Walker DJ; Greenfield JR, 2020, 'Letter to the editor: ⇜risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry”', Journal of Clinical Endocrinology and Metabolism, 105, pp. 1 - 2, http://dx.doi.org/10.1210/clinem/dgaa383
    Journal articles | 2020
    Snaith JR; Holmes-Walker DJ; Greenfield JR, 2020, 'Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?', Trends in Endocrinology and Metabolism, 31, pp. 150 - 164, http://dx.doi.org/10.1016/j.tem.2019.11.007
    Journal articles | 2020
    Snaith JR; Samocha-Bonet D; Holmes-Walker DJ; Greenfield JR, 2020, 'MON-LB113 Insulin Resistance in Type 1 Diabetes Managed With Metformin (INTIMET): Rationale and Study Design of a Randomised Placebo-Controlled Trial', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.2038
    Journal articles | 2019
    Abdel Shaheed C; Carland JE; Graham GG; Stocker SL; Smith G; Hicks M; Williams KM; Furlong T; Macdonald P; Greenfield JR; Smith FC; Chowdhury G; Day RO, 2019, 'Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis', British Journal of Clinical Pharmacology, 85, pp. 2772 - 2783, http://dx.doi.org/10.1111/bcp.14107
    Journal articles | 2019
    Bishay RH; Tonks KT; George J; Samocha-Bonet D; Chisholm DJ; James DE; Greenfield JR, 2019, 'Circulating bile acids are associated with insulin resistance and visceral and liver fat in human subjects', Obesity Research & Clinical Practice, 13, pp. 28 - 29, http://dx.doi.org/10.1016/j.orcp.2016.10.030
    Journal articles | 2019
    Cehic MG; Muir CA; Greenfield JR; Hayward C; Jabbour A; Keogh A; Kotlyar E; Muthiah K; Macdonald PS, 2019, 'Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients', Transplantation Direct, 5, pp. e450, http://dx.doi.org/10.1097/TXD.0000000000000885
    Journal articles | 2019
    Greenfield J, 2019, 'Challenges to obesity research in humans: the power of human phenomic studies', Obesity Research & Clinical Practice, 13, pp. 272 - 272, http://dx.doi.org/10.1016/j.orcp.2018.11.106
    Journal articles | 2019
    Greenfield JR; Carette C; Czernichow S, 2019, 'Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults', The New England journal of medicine, 381, pp. e17, http://dx.doi.org/10.1056/NEJMc1908751
    Journal articles | 2019
    Koay YC; Yang P; Chen D; Jenkins AB; Greenfield J; O'Sullvan JF; Samocha-Bonet D, 2019, 'Novel circulating biomarkers identify insulin resistance phenotypes in obesity', Obesity Research & Clinical Practice, 13, pp. 267 - 268, http://dx.doi.org/10.1016/j.orcp.2018.11.092
    Journal articles | 2019
    Lenders NF; Greenfield JR, 2019, 'Urinary steroid profiling in diagnostic evaluation of an unusual adrenal mass', Endocrinology, Diabetes and Metabolism Case Reports, 2019, http://dx.doi.org/10.1530/EDM-19-0090
    Journal articles | 2019
    Milder TY; Stocker SL; Samocha-Bonet D; Day RO; Greenfield JR, 2019, 'Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease', European Journal of Clinical Pharmacology, 75, pp. 1481 - 1490, http://dx.doi.org/10.1007/s00228-019-02732-y
    Journal articles | 2019
    Milder TY; Stocker SL; Shaheed CA; McGrath-Cadell L; Samocha-Bonet D; Greenfield JR; Day RO, 2019, 'Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis', JOURNAL OF CLINICAL MEDICINE, 8, http://dx.doi.org/10.3390/jcm8010045
    Journal articles | 2019
    Muir C; Dwight T; Center J; Greenfield J; Clifton-Bligh R; Lee P, 2019, 'MON-378 Somatic HIF2α Mutation and Pheochromocytoma in a Patient with Cyanotic Congenital Heart Disease', Journal of the Endocrine Society, 3, http://dx.doi.org/10.1210/js.2019-mon-378
    Journal articles | 2019
    Patel S; Chin V; Greenfield JR, 2019, 'Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism', Endocrinology, Diabetes and Metabolism Case Reports, 2019, http://dx.doi.org/10.1530/EDM-19-0098
    Journal articles | 2019
    Snaith JR; Holmes-Walker DJ; Girgis CM; Greenfield JR, 2019, 'Excess mortality and cardiovascular disease risk in type 1 diabetes', The Lancet, 393, pp. 984 - 985, http://dx.doi.org/10.1016/S0140-6736(18)33050-2
    Journal articles | 2019
    Snaith JR; Holmes-Walker DJ; Greenfield JR, 2019, 'Association of insulin dose, cardiometabolic risk factors, and cardiovascular disease in type 1 diabetes during 30 years of follow-up in the DCCT/EDIC study. Diabetes care 2019;42:657-664', Diabetes Care, 42, pp. E135 - E136, http://dx.doi.org/10.2337/dc19-0730
    Journal articles | 2019
    Tang A; Coster ACF; Tonks KT; Heilbronn LK; Pocock N; Purtell L; Govendir M; Blythe J; Zhang J; Xu A; Chisholm DJ; Johnson NA; Greenfield JR; Samocha-Bonet D, 2019, 'Longitudinal changes in insulin resistance in normal weight, overweight and obese individuals', Journal of Clinical Medicine, 8, pp. 623, http://dx.doi.org/10.3390/jcm8050623
    Journal articles | 2019
    Tang A; Tonks KT; Heilbronn LK; Pocock NA; Campbell LV; James DE; Chisholm DJ; Greenfield JR; Samocha-Bonet D, 2019, 'Insulin-sensitive overweight/obese individuals remain as insulin sensitive and normotensive as lean subjects over 6 years', Obesity Research & Clinical Practice, 13, pp. 35 - 35, http://dx.doi.org/10.1016/j.orcp.2016.10.042
    Journal articles | 2019
    Taylor JE; Campbell LV; Greenfield JR, 2019, 'Author reply', Internal Medicine Journal, 49, pp. 552, http://dx.doi.org/10.1111/imj.14255
    Journal articles | 2018
    Cehic MG; Nundall N; Greenfield JR; Macdonald PS, 2018, 'Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review', Journal of Transplantation, 2018, pp. 1025893, http://dx.doi.org/10.1155/2018/1025893
    Journal articles | 2018
    Du YT; Piscitelli D; Ahmad S; Trahair LG; Greenfield JR; Samocha-Bonet D; Rayner CK; Horowitz M; Jones KL, 2018, 'Effects of glutamine on gastric emptying of lowand high-nutrient drinks in healthy young subjects—impact on glycaemia', Nutrients, 10, http://dx.doi.org/10.3390/nu10060739
    Journal articles | 2018
    Fazakerley DJ; Chaudhuri R; Yang P; Maghzal GJ; Thomas KC; Krycer JR; Humphrey SJ; Parker BL; Fisher-Wellman KH; Meoli CC; Hoffman NJ; Diskin C; Burchfield JG; Cowley MJ; Kaplan W; Modrusan Z; Kolumam G; Yang JYH; Chen DL; Samocha-Bonet D; Greenfield JR; Hoehn KL; Stocker R; James DE; Chen D; Southwell Keely P, 2018, 'Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance', eLife, 7, pp. e32111, http://dx.doi.org/10.7554/eLife.32111
    Journal articles | 2018
    Fazekas-Lavu M; Reyes M; Malouf M; Plit M; Havryk A; Campbell LV; Center JR; Glanville AR; Greenfield JR, 2018, 'High prevalence of diabetes before and after lung transplantation: target for improving outcome?', Internal Medicine Journal, 48, pp. 916 - 924, http://dx.doi.org/10.1111/imj.13963
    Journal articles | 2018
    Greenfield JR; Ho K, 2018, 'Paul Lee, 1977-2017', Internal medicine journal, 48, pp. 381 - 382, http://dx.doi.org/10.1111/imj.13760
    Journal articles | 2018
    Htet TD; Campbell L; Greenfield J, 2018, 'Burden of obesity and focus on use of Liraglutide (Saxenda) 3.0mg for weight loss in adults', The Medical Republic
    Journal articles | 2018
    Isaacs M; Costin M; Bova R; Barrett HL; Heffernan D; Samaras K; Greenfield JR, 2018, 'Management of amiodarone-induced thyrotoxicosis at a cardiac transplantation centre', Frontiers in Endocrinology, 9, http://dx.doi.org/10.3389/fendo.2018.00482
    Journal articles | 2018
    Kumar SS; McManus H; Radovich T; Greenfield JR; Viardot A; Williams KM; Cronin P; Day RO, 2018, 'Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)', European Journal of Clinical Pharmacology, 74, pp. 1327 - 1332, http://dx.doi.org/10.1007/s00228-018-2506-5
    Journal articles | 2018
    Lasschuit J; Greenfield J, 2018, 'Managing complex cases of diabetes', Endocrinology Today, 7, pp. 20 - 24
    Journal articles | 2018
    Ma C; Tonks KT; Center JR; Samocha-Bonet D; Greenfield JR, 2018, 'Complex interplay among adiposity, insulin resistance and bone health', Clinical Obesity, 8, pp. 131 - 139, http://dx.doi.org/10.1111/cob.12240
    Journal articles | 2018
    Samocha-Bonet D; Debs S; Greenfield JR, 2018, 'Prevention and Treatment of Type 2 Diabetes: A Pathophysiological-Based Approach', Trends in Endocrinology and Metabolism, 29, pp. 370 - 379, http://dx.doi.org/10.1016/j.tem.2018.03.014
    Journal articles | 2018
    Taylor JE; Campbell LV; Zhang L; Greenfield JR, 2018, 'High diabetes prevalence and insulin medication errors in hospital patients', Internal Medicine Journal, 48, pp. 1529 - 1532, http://dx.doi.org/10.1111/imj.14124
    Journal articles | 2017
    Bishay RH; Greenfield JR, 2017, 'A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY', Medical Journal of Australia, 207, pp. 223 - 223.e1, http://dx.doi.org/10.5694/mja16.01467
    Journal articles | 2017
    Chemmanam J; Isaacs M; Jones GR; Greenfield JR; Burt MG, 2017, 'Interpreting insulin immunoassays during investigation of apparent spontaneous hypoglycaemia and insulin overdose', Internal Medicine Journal, 47, pp. 1448 - 1451, http://dx.doi.org/10.1111/imj.13644
    Journal articles | 2017
    Chen DLT; Brown R; Liess C; Poljak A; Xu A; Zhang J; Trenell M; Jenkins A; Chisholm D; Samocha-Bonet D; Macefield VG; Greenfield JR; Chen D; Milliken S; Goodnow C, 2017, 'Muscle sympathetic nerve activity is associated with liver insulin sensitivity in obese non-diabetic men', Frontiers in Physiology, 8, pp. 101, http://dx.doi.org/10.3389/fphys.2017.00101
    Journal articles | 2017
    Isaacs M; Tonks KT; Greenfield JR, 2017, 'Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors', Internal Medicine Journal, 47, pp. 701 - 704, http://dx.doi.org/10.1111/imj.13442
    Journal articles | 2017
    Kozan P; Blythe JC; Greenfield JR; Samocha-Bonet D, 2017, 'The effect of buffering high acid load meal with sodium bicarbonate on postprandial glucose metabolism in humans—A randomized placebo-controlled study', Nutrients, 9, pp. 861, http://dx.doi.org/10.3390/nu9080861
    Journal articles | 2017
    Muir CA; Greenfield JR; MacDonald PS, 2017, 'Empagliflozin in the management of diabetes mellitus after cardiac transplantation', Journal of Heart and Lung Transplantation, 36, pp. 914 - 916, http://dx.doi.org/10.1016/j.healun.2017.05.005
    Journal articles | 2017
    Petersons CJ; Mangelsdorf BL; Poljak A; Smith MD; Greenfield JR; Thompson CH; Burt MG, 2017, 'Low dose prednisolone and insulin sensitivity differentially affect arterial stiffness and endothelial function: An open interventional and cross-sectional study', Atherosclerosis, 258, pp. 34 - 39, http://dx.doi.org/10.1016/j.atherosclerosis.2017.01.033
    Journal articles | 2017
    Tonks KT; White CP; Center JR; Samocha-Bonet D; Greenfield JR, 2017, 'Bone turnover is suppressed in insulin resistance, independent of adiposity', Journal of Clinical Endocrinology and Metabolism, 102, pp. 1112 - 1121, http://dx.doi.org/10.1210/jc.2016-3282
    Journal articles | 2016
    Bishay RH; Greenfield JR, 2016, 'A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY', Medical Journal of Australia, 205, pp. 480 - 485, http://dx.doi.org/10.5694/MJA16.00458
    Journal articles | 2016
    Chen DL; Liess C; Poljak A; Xu A; Zhang J; Thoma C; Trenell M; Milner B; Jenkins AB; Chisholm DJ; Samocha-Bonet D; Greenfield JR, 2016, 'Erratum: Phenotypic Characterization of Insulin-Resistant and Insulin-Sensitive Obesity (Journal of Clinical Endocrinology and Metabolism 2015 100(11): (4082-4091)); doi: 10.1210/jc.2015-2712', Journal of Clinical Endocrinology and Metabolism, 101, pp. 757, http://dx.doi.org/10.1210/jc.2015-4260
    Journal articles | 2016
    De Sousa SMC; Haghighi KS; Qiu MR; Greenfield JR; Chen DLT, 2016, 'Synchronous Nesidioblastosis, Endocrine Microadenoma, and Intraductal Papillary Mucinous Neoplasia in a Man Presenting with Hyperinsulinemic Hypoglycemia', Pancreas, 45, pp. 154 - 159, http://dx.doi.org/10.1097/MPA.0000000000000430
    Journal articles | 2016
    He J; Chen DL; Samocha-Bonet D; Gillinder KR; Barclay JL; Magor GW; Perkins AC; Greenfield JR; Yang G; Whitehead JP, 2016, 'Fibroblast growth factor-1 (FGF-1) promotes adipogenesis by downregulation of carboxypeptidase A4 (CPA4)–a negative regulator of adipogenesis implicated in the modulation of local and systemic insulin sensitivity', Growth Factors, 34, pp. 210 - 216, http://dx.doi.org/10.1080/08977194.2017.1285764
    Journal articles | 2016
    Lam T; Hoffman DM; Cukier K; Darnell D; Greenfield JR; Harrison N; Hng TM; Morrow AF; Cheung NW, 2016, 'Temporal HbA1c patterns amongst patients with type 2 diabetes referred for specialist care: Data from the S4S-DINGO-Diabetes Informatics Group', Diabetes Research and Clinical Practice, 116, pp. 159 - 164, http://dx.doi.org/10.1016/j.diabres.2016.04.006
    Journal articles | 2016
    Lee P; Bova R; Schofield L; Bryant W; Dieckmann W; Slattery A; Govendir MA; Emmett L; Greenfield JR, 2016, 'Brown Adipose Tissue Exhibits a Glucose-Responsive Thermogenic Biorhythm in Humans', Cell Metabolism, 23, pp. 602 - 609, http://dx.doi.org/10.1016/j.cmet.2016.02.007
    Journal articles | 2016
    Lee-Young RS; Hoffman NJ; Murphy KT; Henstridge DC; Samocha-Bonet D; Siebel AL; Iliades P; Zivanovic B; Hong YH; Colgan TD; Kraakman MJ; Bruce CR; Gregorevic P; McConell GK; Lynch GS; Drummond GR; Kingwell BA; Greenfield JR; Febbraio MA; Milliken S; Goodnow C, 2016, 'Glucose-6-phosphate dehydrogenase contributes to the regulation of glucose uptake in skeletal muscle', Molecular Metabolism, 5, pp. 1083 - 1091, http://dx.doi.org/10.1016/j.molmet.2016.09.002
    Journal articles | 2016
    Moon J; Kumar SS; Graham GG; Baysari MT; Williams KM; Chen W; Viardot A; Greenfield JR; Day RO, 2016, 'Trends in metformin utilisation and dose appropriateness in Australia', European Journal of Clinical Pharmacology, 72, pp. 1489 - 1496, http://dx.doi.org/10.1007/s00228-016-2117-y
    Journal articles | 2016
    Smith FC; Kumar SS; Furlong TJ; Gangaram SV; Greenfield JR; Stocker SL; Graham GG; Williams KM; Day RO, 2016, 'Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration', American Journal of Kidney Diseases, 68, pp. 990 - 992, http://dx.doi.org/10.1053/j.ajkd.2016.08.017
    Journal articles | 2016
    Tonks KT; Coster AC; Christopher MJ; Chaudhuri R; Xu A; Gagnon-Bartsch J; Chisholm DJ; James DE; Meikle PJ; Greenfield JR; Samocha-Bonet D; Milliken S; Goodnow C, 2016, 'Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans', Obesity, 24, pp. 908 - 916, http://dx.doi.org/10.1002/oby.21448
    Journal articles | 2015
    Chaudhuri R; Khoo PS; Tonks K; Junutula JR; Kolumam G; Modrusan Z; Samocha-Bonet D; Meoli CC; Hocking S; Fazakerley DJ; Stöckli J; Hoehn KL; Greenfield JR; Yang JYH; James DE; Milliken S; Goodnow C, 2015, 'Cross-species gene expression analysis identifies a novel set of genes implicated in human insulin sensitivity', npj Systems Biology and Applications, 1, pp. 15010, http://dx.doi.org/10.1038/npjsba.2015.10
    Journal articles | 2015
    Chen DL; Liess C; Poljak A; Xu A; Zhang J; Thoma C; Trenell M; Milner B; Jenkins AB; Chisholm DJ; Samocha-Bonet D; Greenfield JR, 2015, 'Phenotypic characterization of insulin-resistant and insulin-sensitive obesity', Journal of Clinical Endocrinology and Metabolism, 100, pp. 4082 - 4091, http://dx.doi.org/10.1210/jc.2015-2712
    Journal articles | 2015
    Duong JK; Kumar SS; Furlong TJ; Kirkpatrick CM; Graham GG; Greenfield JR; Williams KM; Day RO, 2015, 'The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitus', British Journal of Clinical Pharmacology, 79, pp. 617 - 623, http://dx.doi.org/10.1111/bcp.12525
    Journal articles | 2015
    Greenfield JRF; Kuhn S; Mehler D; Puel F; Rommens PM, 2015, 'Biomechanical evaluation of a new treatment method for distal tibia fractures', COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, 18, pp. 1952 - 1953, http://dx.doi.org/10.1080/10255842.2015.1069582
    Journal articles | 2015
    Kozusko K; Tsang VHM; Bottomley W; Cho YH; Gandotra S; Mimmack M; Lim K; Isaac I; Patel S; Saudek V; O'Rahilly S; Srinivasan S; Greenfield JR; Barroso I; Campbell LV; Savage DB, 2015, 'Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy', Diabetes, 64, pp. 299 - 310, http://dx.doi.org/10.2337/db14-0104
    Journal articles | 2015
    Lee P; Greenfield JR, 2015, ''Hyperaldosteronaemic or normocalcaemic' hyperparathyroidism?', Clinical Endocrinology, 83, pp. 748 - 749, http://dx.doi.org/10.1111/cen.12771
    Journal articles | 2015
    Lee P; Greenfield JR, 2015, 'Non-pharmacological and pharmacological strategies of brown adipose tissue recruitment in humans', Molecular and Cellular Endocrinology, 418, pp. 184 - 190, http://dx.doi.org/10.1016/j.mce.2015.05.025
    Journal articles | 2015
    Lee P; Greenfield JR, 2015, 'What is the optimal bone-preserving strategy for patients with Addison's disease?', Clinical Endocrinology, 83, pp. 157 - 161, http://dx.doi.org/10.1111/cen.12730
    Journal articles | 2015
    Lee P; Swarbrick MM; Greenfield JR, 2015, 'The sum of all browning in FGF21 therapeutics', Cell Metabolism, 21, pp. 795 - 796, http://dx.doi.org/10.1016/j.cmet.2015.05.018
    Journal articles | 2015
    Samocha-Bonet D; Chisholm DJ; Holst JJ; Greenfield JR; Milliken S; Goodnow C, 2015, 'L-glutamine and whole protein restore first-phase insulin response and increase glucagon-like peptide-1 in type 2 diabetes patients', Nutrients, 7, pp. 2101 - 2108, http://dx.doi.org/10.3390/nu7042101
    Journal articles | 2015
    Sapkota S; Brien J-AE; Greenfield JR; Aslani P, 2015, 'A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes—Components of Interventions', PLOS ONE, 10, pp. e0128581 - e0128581, http://dx.doi.org/10.1371/journal.pone.0128581
    Journal articles | 2015
    Sapkota S; Brien JA; Greenfield J; Aslani P, 2015, 'A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes - Impact on adherence', PLoS ONE, 10, http://dx.doi.org/10.1371/journal.pone.0118296
    Journal articles | 2015
    Sapkota S; Brien JAE; Greenfield JR; Aslani P; Brien J-A; Milliken S; Goodnow C, 2015, 'A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes - Components of interventions', PLoS ONE, 10, pp. e0128581, http://dx.doi.org/10.1371/journal.pone.0128581
    Journal articles | 2015
    Wiley J; Westbrook M; Long J; Greenfield JR; Day RO; Braithwaite J, 2015, 'Multidisciplinary diabetes team care: The experiences of young adults with Type 1 diabetes', Health Expectations, 18, pp. 1783 - 1796, http://dx.doi.org/10.1111/hex.12170
    Journal articles | 2015
    Williams RS; Heilbronn LK; Chen DL; Coster A; Greenfield JR; Samocha-Bonet D; Milliken S; Goodnow C; Chen D, 2015, 'Dietary acid load, metabolic acidosis and insulin resistance - Lessons from cross-sectional and overfeeding studies in humans', Clinical Nutrition, 35, pp. 1084 - 1090, http://dx.doi.org/10.1016/j.clnu.2015.08.002
    Journal articles | 2014
    Greenfield JR, 2014, 'Pharmacological and non-pharmacological glp-1 receptor stimulants.', Pathology, 46 Suppl 1, pp. S15, http://dx.doi.org/10.1097/01.PAT.0000443444.29573.26
    Journal articles | 2014
    Meretoja A; Churilov L; Campbell BCV; Aviv RI; Yassi N; Barras C; Mitchell P; Yan B; Nandurkar H; Bladin C; Wijeratne T; Spratt NJ; Jannes J; Sturm J; Rupasinghe J; Zavala J; Lee A; Kleinig T; Markus R; Delcourt C; Mahant N; Parsons MW; Levi C; Anderson CS; Donnan GA; Davis SM, 2014, 'The Spot sign and Tranexamic acid On Preventing ICH growth - AUStralasia Trial (STOP-AUST): Protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial', International Journal of Stroke, 9, pp. 519 - 524, http://dx.doi.org/10.1111/ijs.12132
    Journal articles | 2014
    Samocha-Bonet D; Chisholm DJ; Gribble FM; Coster ACF; Carpenter KH; Jones GRD; Holst JJ; Greenfield JR, 2014, 'Glycemic effects and safety of L-glutamine supplementation with or without sitagliptin in type 2 diabetes patients-a randomized study', PLoS ONE, 9, pp. e113366, http://dx.doi.org/10.1371/journal.pone.0113366
    Journal articles | 2014
    Tang A; Milner KL; Tonks K; Campbell LV; Greenfield JR, 2014, 'Comment on Brethauer et al. Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes Care 2014;37:e51-e52', Diabetes Care, 37, pp. e248 - e249, http://dx.doi.org/10.2337/dc14-0578
    Journal articles | 2014
    Tonks K; White C; Center J; Chisholm DJ; Greenfield JR; Samocha-Bonet D, 2014, 'Bone phenotype of insulin-resistant and insulin-sensitive overweight and obese humans', Obesity Research & Clinical Practice, 8, pp. 103 - 104, http://dx.doi.org/10.1016/j.orcp.2014.10.189
    Journal articles | 2014
    Wiley J; Westbrook M; Greenfield JR; Day RO; Braithwaite J, 2014, 'Shared decision-making: The perspectives of young adults with type I diabetes mellitus', Patient Preference and Adherence, 8, pp. 423 - 435, http://dx.doi.org/10.2147/PPA.S57707
    Journal articles | 2014
    Wiley J; Westbrook M; Long J; Greenfield JR; Day RO; Braithwaite J, 2014, 'Diabetes Education: the Experiences of Young Adults with Type 1 Diabetes', Diabetes Therapy, 5, pp. 299 - 321, http://dx.doi.org/10.1007/s13300-014-0056-0
    Journal articles | 2013
    Chang J; Wu T; Greenfield JR; Samocha-Bonet D; Horowitz M; Rayner CK, 2013, 'Effects of Intraduodenal Glutamine on Incretin Hormone and Insulin Release, the Glycemic Response to an Intraduodenal Glucose Infusion, and Antropyloroduodenal Motility in Health and Type 2 Diabetes', Diabetes Care, 36, pp. 2262 - 2265, http://dx.doi.org/10.2337/dc12-1663
    Journal articles | 2013
    Gifford G; Milliken S; Greenfield J, 2013, 'Diabetic ketoacidosis secondary to L-asparaginase in acute lymphoblastic leukaemia', Internal Medicine Journal, 43, pp. 946 - 948, http://dx.doi.org/10.1111/imj.12216
    Journal articles | 2013
    Heilbronn LK; Coster ACF; Campbell LV; Greenfield JR; Lange K; Christopher MJ; Meikle PJ; Samocha-Bonet D, 2013, 'The effect of short-term overfeeding on serum lipids in healthy humans', Obesity, 21, pp. e649 - e659, http://dx.doi.org/10.1002/oby.20508
    Journal articles | 2013
    Hocking S; Samocha-Bonet D; Milner KL; Greenfield JR; Chisholm DJ, 2013, 'Adiposity and insulin resistance in humans: The role of the different tissue and cellular lipid depots', Endocrine Reviews, 34, pp. 463 - 500, http://dx.doi.org/10.1210/er.2012-1041
    Journal articles | 2013
    Jenkins AB; Batterham M; Samocha-Bonet D; Tonks K; Greenfield JR; Campbell LV, 2013, 'Segregation of a Latent High Adiposity Phenotype in Families with a History of Type 2 Diabetes Mellitus Implicates Rare Obesity-Susceptibility Genetic Variants with Large Effects in Diabetes-Related Obesity', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0070435
    Journal articles | 2013
    Lee P; Day RO; Greenfield JR; Ho KK, 2013, 'Formoterol, a highly selective beta 2-selective agonist, increases energy expenditure and fat utilisation in men', International journal of obesity, 37, pp. 593 - 597, http://dx.doi.org/10.1038/ijo.2012.90
    Journal articles | 2013
    Petersons CJ; Mangelsdorf BL; Jenkins AB; Poljak A; Smith MD; Greenfield JR; Thompson CH; Burt MG, 2013, 'Effects of low-dose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease', Diabetes Care, 36, pp. 2822 - 2829, http://dx.doi.org/10.2337/dc12-2617
    Journal articles | 2013
    Tonks KT; Ng Y; Miller S; Coster ACF; Samocha-Bonet D; Iseli TJ; Xu A; Patrick E; Yang JYH; Junutula JR; Modrusan Z; Kolumam G; Stöckli J; Chisholm DJ; James DE; Greenfield JR; Stoeckli J, 2013, 'Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous downstream defects', Diabetologia, 56, pp. 875 - 885, http://dx.doi.org/10.1007/s00125-012-2811-y
    Journal articles | 2013
    Wiley J; Westbrook M; Long J; Greenfield JR; Day RO; Braithwaite J, 2013, 'Multidisciplinary diabetes team care: The experiences of young adults with Type 1 diabetes', Health Expectations, http://dx.doi.org/10.1111/hex.12170
    Journal articles | 2012
    Chen D; Tonks K; Greenfield JR; El nouty C; Hercberg S; Czernichow S, 2012, 'Thyroid volume predicts body mass index 2 and 6 years later', Journalof Clinical Endocrinology and Metabolism, 2, pp. 105 - 109, http://dx.doi.org/10.4021/jem99w
    Journal articles | 2012
    Chen DL; Goldrick A; Greenfield JR, 2012, 'Severe Symptomatic Hypocalcaemia Following High-Dose Oral Ibandronate in a Patient With Prior Thyroidectomy and Metastatic Bone Disease', JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2, pp. 96 - 98, http://dx.doi.org/10.4021/jem96w
    Journal articles | 2012
    Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'Metformin therapy in patients with chronic kidney disease', Diabetes Obesity and Metabolism, 14, pp. 963 - 965, http://dx.doi.org/10.1111/j.1463-1326.2012.01617.x
    Journal articles | 2012
    Gentilcore D; Ahmad S; Jones K; Greenfield J; Samocha-Bonet D; Mckinnon R, 2012, 'Effects of the amino acid, glutamine, on gastric emptying and the glycaemic response to oral glucose in healthry young subjects', NEUROGASTROENTEROLOGY AND MOTILITY, 24, pp. 170 - 170, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308435400561&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2012
    Greenfield JR; Mccormack AI, 2012, 'Medication to prevent breast cancer too much to swallow?', Medical Journal of Australia, 196, pp. 314, http://dx.doi.org/10.5694/mja12.10056
    Journal articles | 2012
    Lee P; Greenfield JR; Gilbert K; Campbell LV, 2012, 'Recreational drug use in type 1 diabetes: An invisible accomplice to poor glycaemic control?', Internal Medicine Journal, 42, pp. 198 - 202, http://dx.doi.org/10.1111/j.1445-5994.2011.02653.x
    Journal articles | 2012
    Myint KS; Greenfield JR; Farooqi IS; Henning E; Holst JJ; Finer N, 2012, 'Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: The pathophysiological role of GLP1 and its response to a somatostatin analogue', European Journal of Endocrinology, 166, pp. 951 - 955, http://dx.doi.org/10.1530/EJE-11-1065
    Journal articles | 2012
    Samocha-Bonet D; Campbell LV; Mori TA; Croft KD; Greenfield JR; Turner N; Heilbronn LK, 2012, 'Overfeeding reduces insulin sensitivity and increases oxidative stress, without altering markers of mitochondrial content and function in humans', PLoS One, 7, pp. e36320, http://dx.doi.org/10.1371/journal.pone.0036320
    Journal articles | 2012
    Samocha-Bonet D; Chisholm DJ; Tonks K; Campbell LV; Greenfield JR, 2012, 'Insulin-sensitive obesity in humans - a 'favorable fat' phenotype?', Trends Endocrinol Metab, 23, pp. 116 - 124, http://dx.doi.org/10.1016/j.tem.2011.12.005
    Journal articles | 2011
    Abdo S; Greenfield JR, 2011, 'What to do about Bones in those on Prednisone?', Geriatric Medicine in General Practice, 8, pp. 23 - 25, http://search.informit.com.au/documentSummary;dn=108998177284356;res=IELHEA
    Journal articles | 2011
    Graham GG; Punt J; Manit A; Day RO; Doogue MP; Duong JK; Furlong TJ; Greenfield JR; Greenup L; Carl m kirkpatrick CM; Ray J; Timmins P; Williams KM, 2011, 'Clinical pharmacokinetics of metformin', Clinical Pharmacokinetics, 50, pp. 81 - 98, http://dx.doi.org/10.2165/11534750-000000000-00000
    Journal articles | 2011
    Greenfield JR; Graham GG; Day RO, 2011, 'The Use of Metformin in Diabetic Patients with Renal Impairment', Geriatric Medicine in General Practice, 8, pp. 26 - 29, http://search.informit.com.au/documentSummary;dn=109054076198131;res=IELHEA
    Journal articles | 2011
    Greenfield JR, 2011, 'Melanocortin signalling and the regulation of blood pressure in human obesity', Journal of Neuroendocrinology, 23, pp. 186 - 193, http://dx.doi.org/10.1111/j.1365-2826.2010.02088.x
    Journal articles | 2011
    Lee P; Ho KK; Greenfield JR, 2011, 'Hot fat in a cool man: infrared thermography and brown adipose tissue', Diabetes Obesity and Metabolism, 13, pp. 92 - 93, http://dx.doi.org/10.1111/j.1463-1326.2010.01318.x
    Journal articles | 2011
    Lee P; Ho KK; Greenfield JR, 2011, 'Hypothalamic/Pituitary morbility in skull base pathology', Otolaryngologic Clinics of North America, 44, pp. 1005 - 1021, http://dx.doi.org/10.1016/j.otc.2011.06.010
    Journal articles | 2011
    Lee P; Kengne A; Greenfield JR; Day RO; Chalmers J; Ho KK, 2011, 'Metabolic sequelae of beta-blocker theraphy: weighing in on the obesity epidemic?', International journal of obesity, 35, pp. 1395 - 1403, http://dx.doi.org/10.1038/ijo.2010.284
    Journal articles | 2011
    Lee P; Zhao JT; Swarbrick MM; Gracie G; Bova RJ; Greenfield JR; Freund J; Ho KK, 2011, 'High prevalence of brown adipose tissue in adult humans', Journal of Clinical Endocrinology and Metabolism, 96, pp. 2450 - 2455, http://dx.doi.org/10.1210/jc.2011-0487
    Journal articles | 2011
    Martinelli CE; Keogh JM; Greenfield JR; Henning L; Van der klaauw A; Blackwood D; O''Rahilly S; Roelfsema F; Camacho M; Pijl H; Farooqi S, 2011, 'Obesity due to Melanocortin 4 Receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting, hyperinsulinemia, and incompletely suppressed Growth Hormone secretion', Journal of Clinical Endocrinology and Metabolism, 96, pp. E181 - E188, http://dx.doi.org/10.1210/jc.2010-1369
    Journal articles | 2011
    Samocha-Bonet D; Wong O; Synnott EL; Piyaratna N; Douglas A; Gribble FM; Holst JJ; Chisholm DJ; Greenfield JR, 2011, 'Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients', J Nutr, 141, pp. 1233 - 1238, http://dx.doi.org/10.3945/jn.111.139824
    Journal articles | 2011
    Tonks KT; Ng Y; Miller S; Coster ACF; Samocha-Bonet D; Iseli TJ; Xu A; Stöckli J; Chisholm DJ; James DE; Greenfield JR, 2011, 'Obese, yet insulin sensitive humans', Obesity Research & Clinical Practice, 5, pp. 13 - 13, http://dx.doi.org/10.1016/j.orcp.2011.08.079
    Journal articles | 2010
    Czernichow S; Greenfield JR; Galan P; Bastard JP; Charnaux N; Samaras K; Safar M; Blacher J; Hercberg S; Levi BI, 2010, 'Microvascular dysfunction in healthy insulin-sensitive overweight individuals', Journal of Hypertension, 28, pp. 325 - 332
    Journal articles | 2010
    Czernichow S; Greenfield JR; Galan P; Jellouli F; Safar M; Blacher J; Hercberg S; Levi BI, 2010, 'Macrovascular and microvascular dysfunction in the metabolic syndrome', Hypertension Research, 33, pp. 293 - 297
    Journal articles | 2010
    Czernichow S; Lee C; Barzi F; Greenfield JR; Baur LA; Chalmers J; Woodward M; Huxley R, 2010, 'Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials', Obesity Reviews, 11, pp. 150 - 158
    Journal articles | 2010
    Killen J; Tonks K; Greenfield JR; Story D, 2010, 'New insulin analogues and perioperative care of patients with type 1 diabetes', Anaesthesia and Intensive Care, 38, pp. 244 - 249
    Journal articles | 2010
    Killen J; Tonks K; Greenfield JR; Story DA, 2010, 'Review: New insulin analogues and perioperative care of patients with type 1 diabetes (Anaesthesia and Intensive Care (2010) 38, (244-249))', Anaesthesia and Intensive Care, 38, pp. 770
    Journal articles | 2010
    Lee P; Greenfield JR; Ho KK; Fulham MJ, 2010, 'A critical appraisal of prevalence and metabolic signifigance of brown adipose tissue in adult humans', American Journal of Physiology - Endocrinology and Metabolism, 299, pp. E601 - E606
    Journal articles | 2010
    Lee P; Zhao JT; Swarbrick M; Bova R; Gracie G; Freund J; Greenfield JR; Ho KKY, 2010, 'OR9,51 Brown adipose tissue is present in PET negative supraclavicular fat in adult humans', Growth Hormone & IGF Research, 20, pp. S23 - S24, http://dx.doi.org/10.1016/s1096-6374(10)70065-4
    Journal articles | 2010
    Tam CS; Viardot A; Clement K; Tordjman J; Tonks K; Greenfield JR; Campbell LV; Samocha-Bonet D; Heilbronn LK, 2010, 'Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans', Diabetes, 59, pp. 2164 - 2170, http://dx.doi.org/10.2337/db10-0162
    Journal articles | 2009
    Greenfield JR; Farooqi IS; Keogh JM; Henning E; Habib AM; Blackwood A; Reimann F; Holst JJ; Gribble FM, 2009, 'Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects', American Journal of Clinical Nutrition, 89, pp. 106 - 113, http://dx.doi.org/10.3945/ajcn.2008.26362
    Journal articles | 2009
    Greenfield JR; Miller JW; Keogh JM; Henning E; Satterwhite JH; Cameron GS; Astruc B; Mayer JP; Brage S; See TC; Lomas DJ; O'Rahilly S; Farooqi IS, 2009, 'Modulation of blood pressure by central melanocortinergic pathways', New England Journal of Medicine, 360, pp. 44 - 52, http://dx.doi.org/10.1056/NEJMoa0803085
    Journal articles | 2009
    Greenfield JR; Tuthill A; Soos MA; Semple RK; Halsall DJ; Chaudhry A; O'Rahilly S, 2009, 'Severe insulin resistance due to anti-insulin antibodies: Response to plasma exchange and immunosuppressive therapy', Diabetic Medicine, 26, pp. 79 - 82, http://dx.doi.org/10.1111/j.1464-5491.2008.02621.x
    Journal articles | 2009
    Lee P; Greenfield JR; Campbell LV, 2009, 'Managing young people with Type 1 diabetes in a `rave` new world: Metabolic complications of substance abuse in Type 1 diabetes', Diabetic Medicine, 26, pp. 328 - 333
    Journal articles | 2009
    Lee P; Greenfield JR; Campbell LV, 2009, 'Vitamin D insufficiency - A novel mechanism of statin-induced myalgia?: LETTERS to the EDITOR', Clinical Endocrinology, 71, pp. 154 - 155, http://dx.doi.org/10.1111/j.1365-2265.2008.03448.x
    Journal articles | 2009
    Lee P; Greenfield JR; Campbell LV, 2009, 'Vitamin D insufficiency - a novel mechanism of statin-induced myalgia?', Clinical Endocrinology, 71, pp. 154 - 155
    Journal articles | 2009
    Lee P; Greenfield JR; Center JR; Campbell LV, 2009, 'Plasma insulin concentration is useful to guide glucose supplement in insulin overdose', Intensive Care Medicine, 35, pp. 181 - 182
    Journal articles | 2009
    Lee P; Greenfield JR; Day RO; Ho K, 2009, 'Weight maintenance in hospitalized geriatric patients treated with beta-blockers', Journal of the American Geriatrics Society, 57, pp. 1125 - 1126
    Journal articles | 2009
    Lee P; Greenfield JR; Ho K, 2009, 'Factors determining inadequate hypoglycaemia during insulin tolerance testing (ITT) after pituitary surgery', Clinical Endocrinology, 71, pp. 82 - 85
    Journal articles | 2009
    Lee P; Greenfield JR; Seibel MJ; Eisman JA; Center JR, 2009, 'Adequacy of Vitamin D Replacement in Severe Deficiency Is Dependent on Body Mass Index', American Journal of Medicine, 122, pp. 1056 - 1060
    Journal articles | 2009
    Lee P; Greenfield JR, 2009, '25-Hydroxyvitamin D and Risk of Stroke: Possible Mediation by Statin Therapy?', Stroke, 40, pp. E35 - E35
    Journal articles | 2008
    Czernichow S; Greenfield JR; Safar M, 2008, 'Impact of abdominal adiposity on cardiovascular disease predictors: What is the missing link?', American Journal of Hypertension, 21, pp. 851 - 851
    Journal articles | 2008
    Greenfield JR; Campbell LV, 2008, 'Role of the autonomic nervous system and neuropeptides in the development of obesity in humans: Targets for therapy?', Current Pharmaceutical Design, 14, pp. 1815 - 1820
    Journal articles | 2008
    Lee P; Greenfield JR; Campbell LV, 2008, 'Mind the gap when managing ketoacidosis in type 1 diabetes', Diabetes Care, 31, http://dx.doi.org/10.2337/dc08-0690
    Journal articles | 2008
    Lloret-Linares C; Greenfield JR; Czernichow S, 2008, 'Effect of weight-reducing agents on glycaemic parameters and progression to Type 2 diabetes: a review', Diabetic Medicine, 25, pp. 1142 - 1150
    Journal articles | 2008
    Wong LY; Moore J; Hill D; Brenner P; Delprado W; Turner J; Taylor J; Campbell L; Greenfield JR, 2008, 'Custing's syndrome can precipitate diabetes but mask non-Hodgkin's lymphoma', Medical Journal of Australia, 188, pp. 262, http://dx.doi.org/10.5694/j.1326-5377.2008.tb01608.x
    Journal articles | 2008
    Wong LY; Moore JJ; Hill D; Brenner PC; Delprado W; Turner J; Taylor J; Campbell L; Greenfield JR, 2008, 'Cushing`s syndrome can precipitate diabetes but mask non-Hodgkin`s lymphoma', Medical Journal of Australia, 188, pp. 262 - 262, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000255914800025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2007
    Greenfield JR; Samaras K; Chisholm DJ; Campbell LV, 2007, 'Effect of postpradnial insulinemia and insulin resistance on measurement of arterial stiffness (augmentation index)', International Journal of Cardiology, 114 (1), pp. 50 - 56
    Journal articles | 2006
    Bryant W; Greenfield JR; Chisholm DJ; Campbell LV, 2006, 'Diabetes Guidelines: easier to preach than to practice?', Medical Journal of Australia, 185, pp. 305 - 309
    Journal articles | 2006
    Bryant W; Greenfield JR; Chrisholm DJ; Campbell LV, 2006, 'Diabetes guidelines: Easier to preach than to practise? A retrospective audit of outpatient management of type 1 and type 2 diabetes mellitus', Medical Journal of Australia, 185, pp. 305 - 309, http://dx.doi.org/10.5694/j.1326-5377.2006.tb00583.x
    Journal articles | 2006
    Greenfield JR; Campbell LV, 2006, 'Relationship between inflammation, insulin resistance and type 2 diabetes: 'Cause or effect'?', Current Diabetes Reviews, 2, pp. 195 - 211, http://dx.doi.org/10.2174/157339906776818532
    Journal articles | 2006
    Greenfield JR; Samaras K; Chisholm DJ; Campbell LV, 2006, 'Effect of postprandial insulinemia and insulin resistance on measurement of arterial stiffness (augmentation index)', International Journal of Cardiology, 114, pp. 50 - 56
    Journal articles | 2006
    Greenfield JR; Samaras K, 2006, 'Evaluation of pituitary function in the fatigued patient: a review of 59 cases', European Journal of Endocrinology, 154, pp. 147 - 157
    Journal articles | 2006
    Greenfield JR; Samaras K, 2006, 'Suppression of HPA axis in adults taking inhaled corticosteroids', Thorax, 61, pp. 272 - 273
    Journal articles | 2006
    Meier C; Meinhardt U; Greenfield JR; de Winter J; Nguyen TV; Dunstan C; Seibel MJ, 2006, 'Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget`s disease', Clinical Laboratory, 52, pp. 1 - 10
    Journal articles | 2005
    Greenfield JR; Samaras K; Hayward CS; Chisholm DJ; Campbell LV, 2005, 'Beneficial postprandial effect of a small amount of alcohol on diabetesand cardiovascular risk factors: Modification by insulin resistance', Journal of Clinical Endocrinology and Metabolism, 90, pp. 661 - 672
    Journal articles | 2005
    Meier C; Meinhardt U; Greenfield JR; Dunstan C; Seibel MJ, 2005, 'Serum cathepsin K levels reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget`s disease', Bone, 36, pp. S139 - S140, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229979900081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2005
    Meier C; Meinhardt U; Greenfield JR; Nguyen TV; de Winter J; Seibel MJ, 2005, 'Serum cathepsin K measurements: Repeatability, intra-subject and postprandial variability', Bone, 36, pp. S197 - S197, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229979900206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2004
    Greenfield JR; Campbell LV, 2004, 'Insulin resistance and obesity', Clinics in Dermatology, 22, pp. 289 - 295, http://www.sciencedirect.com/science/article/B6T5G-4DGM0SS-4/2/fa6d5607668192a07aee4cc239ed4eb2
    Journal articles | 2004
    Greenfield JR; Chisholm DJ, 2004, 'Thiazolidinediones - Mechanisms of action', Australian Prescriber, 27, http://dx.doi.org/10.18773/austprescr.2004.059
    Journal articles | 2004
    Greenfield JR; Samaras K; Jenkins AB; Kelly PJ; Spector TD; Campbell LV, 2004, 'Do gene-environment interactions influence fasting plasma lipids? Astudy of twins', European Journal of Clinical Investigation, 34, pp. 590 - 598
    Journal articles | 2004
    Greenfield JR; Samaras K; Jenkins AB; Kelly PJ; Spector TD; Gallimore J; Pepys M; Campbell LV, 2004, 'Obesity is an important determinant of baseline serum C-reactiveprotein concentration in monozygotic twins, independent of geneticinfluences', Circulation, 109, pp. 3022 - 3028
    Journal articles | 2004
    Grubb D; Greenfield JR; Chisholm DJ, 2004, 'Thiazolidinediones (multiple letters) [2]', Australian Prescriber, 27, pp. 139
    Journal articles | 2004
    Kriketos AD; Greenfield JR; Peake PW; Furler SM; Denyer GS; Charlesworth JA; Campbell LV, 2004, 'Inflammation, Insulin Resistance, and Adiposity: A study of first-degree relatives of type 2 diabetic subjects', Diabetes Care, 27, pp. 2033 - 2040, http://www.sciencedirect.com/science/article/B6WVB-4D3R5H1-4MT/2/20d5cadafd9bbe5b03e2de182024dee9
    Journal articles | 2003
    Greenfield JR; Samaras K; Campbell LV; Chisholm DJ, 2003, 'Type 1 diabetes is not associated with increased central abdominal obesity - Response to Sobel', DIABETES CARE, 26, pp. 2703 - 2703, http://dx.doi.org/10.2337/diacare.26.9.2703
    Journal articles | 2003
    Greenfield JR; Samaras K; Campbell LV; Chisholm DJ, 2003, 'Type I diabetes is not associated with increased central abdominal obesity', Diabetes Care, 26, pp. 2703 - 2703
    Journal articles | 2003
    Greenfield JR; Samaras K; Campbell LV; Spector TD; Hayward CS; Jenkins AB; Kelly PJ, 2003, 'Physical activity reduces genetic susceptibility to increased central systolic pressure augmentation: a study of female twins', Journal of the American College of Cardiology, 42, pp. 264 - 270
    Journal articles | 2003
    Greenfield JR; Samaras K; Jenkins AB; Kelly PJ; Spector TD; Campbell LV, 2003, 'Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity: Is abdominal adiposity the mediator?', Diabetes Care, 26, pp. 2734 - 2740, http://dx.doi.org/10.2337/diacare.26.10.2734
    Journal articles | 2003
    Greenfield JR; Samaras K; Spector TD; Campbell LV; Jenkins AB; Kelly PJ, 2003, 'Moderate Alcohol Consumption and oestrogen replacement are associated with insulin sensitivity: is lower abdominal adiposity the mediator?', Diabetes Care, 26, pp. 2734 - 2740
    Journal articles | 2003
    Greenfield JR; Samaras K; Spector TD; Campbell LV; Jenkins AB; Kelly PJ, 2003, 'Moderate Alcohol Consumption, Dietary Fat Composition, and Abdominal Obesity in Women: Evidence of Gene-Environment Interaction', Journal of Clinical Endocrinology and Metabolism, 88, pp. 5381 - 5386
    Journal articles | 2002
    Greenfield JR; McGrath M; Kossard S; Charlesworth JA; Campbell LV, 2002, 'ANCA-positive vasculitis induced by thioridazine: Confirmed by rechallenge [2]', British Journal of Dermatology, 147, pp. 1265 - 1267, http://dx.doi.org/10.1046/j.1365-2133.2002.05000_2.x
    Journal articles | 2002
    Greenfield JR; Samaras K; Chisholm DJ; Campbell LV, 2002, 'Regional intra-subject variability in abdominal adiposity limits usefulness of computed tomography', Obesity Research, 10, pp. 260 - 265, http://dx.doi.org/10.1038/oby.2002.35
    Journal articles | 2002
    Greenfield JR; Samaras K; Chisholm DJ, 2002, 'Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus', Journal of Clinical Endocrinology and Metabolism, 87, pp. 1036 - 1040, http://dx.doi.org/10.1210/jcem.87.3.8324
    Journal articles | 2002
    Greenfield JR; Samaras K; Chisholm DJ, 2002, 'Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus.', J Clin Endocrinol Metab, 87, pp. 1036 - 1040, http://dx.doi.org/10.1210/jcem.87.3.8324
    Journal articles | 2001
    Greenfield JR; Center JR; Freund J; Eisman JA, 2001, 'Treatment of an Atraumatic Fracture: The importance of establishing a definitive diagnosis.', Journal of Bone and Mineral Research, 16, pp. 2362 - 2364
    Journal articles | 2001
    Greenfield JR; Chisholm DJ, 2001, '`Adrenal apoplexy: an inconspicuous cause of hypotension in the intensive care patient.` Clinical review', Medical Journal of Australia, 175, pp. 384 - 385
    Journal articles | 2000
    Greenfield JR; Chisholm DJ, 2000, 'Clinical trials and clinical practice - Bridging the gaps in type 2 diabetes: An evidence-based approach to risk factor modification in type 2 diabetes', Australian and New Zealand Journal of Medicine, 30, pp. 483 - 491, http://dx.doi.org/10.1111/j.1445-5994.2000.tb02056.x
  • Preprints | 2024
    Lutsker G; Sapir G; Godneva A; Shilo S; Greenfield JR; Samocha-Bonet D; Mannor S; Meirom E; Chechik G; Rossman H; Segal E, 2024, From Glucose Patterns to Health Outcomes: A Generalizable Foundation Model for Continuous Glucose Monitor Data Analysis, http://dx.doi.org/10.48550/arxiv.2408.11876
    Conference Abstracts | 2023
    Chavali S; Barua S; Adjii A; Robson D; Raven L; Greenfield J; Parvar S; MacDonald P; Hayward C; Muthiah K, 2023, 'Safety and Tolerability of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients Supported with Left Ventricular Assist Devices', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CO, Denver, Vol. 42, pp. S450 - S451, presented at 43rd Annual Meeting of International Society for Heart and Lung Transplantation (ISHLT), CO, Denver, 19 April 2023 - 22 April 2023, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480601267&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2023
    Lin J; Pearson S; Greenfield J; Park KH; Havard A; Brieger D; Day R; Falster M; de Oliveira Costa J, 2023, 'Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues', in Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues, presented at Australian Diabetes Congress 2023
    Conference Abstracts | 2023
    Lin J; Pearson S; Greenfield J; Park KH; Havard A; Brieger D; Day R; Falster M, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022)', in Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022), presented at 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2023
    Preprints | 2023
    Snaith JR; Olsen N; Greenfield JR, 2023, Statistical Analysis Plan for the INTIMET study (Insulin Resistance in Type 1 Diabetes Managed with Metformin), , http://dx.doi.org/10.1101/2023.11.20.23298602
    Conference Posters | 2022
    Chowdhury G; Carland J; Stocker S; MacDonald P; Greenfield J; Day R, 2022, 'The trends and opinions of Australian clinicians on the use of antihyperglycemic agents in heart failure patients', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2022 - 29 November 2019
    Conference Abstracts | 2022
    Milder T; Stocker S; Baysari M; Day R; Greenfield J, 2022, 'PRESCRIPTION OF SGLT2 INHIBITORS TO PATIENTS WITH CHRONIC KIDNEY DISEASE: A QUALITATIVE STUDY OF NEPHROLOGISTS AND CARDIOLOGISTS', in NEPHROLOGY, WILEY, Vol. 27, pp. 74 - 74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000864433100145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    Perera C; Hossain MJ; Mekapogu AR; Hosen SMZ; Rajan P; Xu Z; Greenfield J; Hoehn K; Horadagoda N; Chari S; Pirola R; Wilson J; Apte MV, 2022, 'PANCREATIC CANCER-RELATED DIABETES: A HIGH FRUCTOSE DIET FED TO TRANSGENIC, KRAS(LSL-G12D/+); PDXCRE/+ (KC) MICE, IS ASSOCIATED WITH PANCREATIC STELLATE CELL ACTIVATION AND ACCELERATED CANCER PROGRESSION', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 162, pp. S562 - S563, presented at Digestive Disease Week (DDW), CA, San Diego, 21 May 2022 - 24 May 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000826446202162&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2022
    Perera C; Hossain MJ; Mekapogu AR; Hosen SMZ; Rajan P; Xu Z; Greenfield J; Hoehn K; Horadagoda N; Chari S; Pirola R; Wilson J; Apte MV, 2022, 'Su1261: PANCREATIC CANCER-RELATED DIABETES: A HIGH FRUCTOSE DIET FED TO TRANSGENIC, KRASLSL-G12D/+; PDXCRE/+ (KC) MICE, IS ASSOCIATED WITH PANCREATIC STELLATE CELL ACTIVATION AND ACCELERATED CANCER PROGRESSION', in Gastroenterology, Elsevier BV, http://dx.doi.org/10.1016/s0016-5085(22)61328-3
    Conference Abstracts | 2022
    Perera C; Hossain MJ; Mekapogu AR; Hosen SMZ; Xu Z; Greenfield J; Hoehn K; Horadagoda N; Pirola R; Wilson J; Apte M; HOSEN SM, 2022, 'Impaired glucose tolerance in transgenic KC mice is associated with pancreatic stellate cell activation and accelerated pancreatic cancer progression', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 32 - 32
    Conference Abstracts | 2022
    Snaith JR; Holmes-Walker DJ; Greenfield JR, 2022, 'Insulin resistance and visceral or ectopic fat deposition may independently determine metabolic and cardiovascular complications in type 1 diabetes', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, Vol. 65, pp. S83 - S83, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000841795900160&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Cohen-Hyams T; Killingsworth M; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'Effects of pancreatic stellate cell- and cancer cell-derived exosomes on islet cell functions: Implications for pancreatic cancer-related diabetes', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'I. Pancreatic Stellate Cell and Cancer Cell Derived Exosomes Impair Beta Cell Function: Implications for Pancreatic Cancer Related Diabetes', in Gastroenterology, Elsevier, Chicago, USA, presented at Digestive Disease Week, Chicago, USA, 02 May 2020, http://dx.doi.org/10.1016/S0016-5085(20)31245-2
    Conference Papers | 2020
    Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'Pancreatic cancer-related diabetes: Do pancreatic stellate cell and cancer cell derived exosomes play a role?', in Pancreratology, presented at European Pancreatic Club
    Conference Papers | 2020
    Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte MV, 2020, 'PANCREATIC STELLATE CELL AND CANCER CELL DERIVED EXOSOMES IMPAIR BETA CELL FUNCTION: IMPLICATIONS FOR PANCREATIC CANCER RELATED DIABETES', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, TX, Austin, pp. S221 - S221, presented at Crohn's and Colitis Congress, TX, Austin, 23 January 2020 - 25 January 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000540349500565&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Cehic M; Greenfield J; Hayward C; Jabbour A; Kotlyar E; Muthiah K; MacDonald P, 2018, 'Impact of Empagliflozin for the Treatment of Diabetes Mellitus after Heart Transplantation', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, SPAIN, Madrid, Vol. 102, pp. S88 - S88, presented at 27th International Congress of the Transplantation-Society (TTS), SPAIN, Madrid, 30 June 2018 - 05 July 2018, http://dx.doi.org/10.1097/01.tp.0000542675.44943.1c
    Conference Abstracts | 2018
    Du YT; Piscitelli D; Ahmad S; Trahair LG; Greenfield JR; Samocha-Bonet D; Rayner CK; Horowitz M; Jones KL, 2018, 'Effects of glutamine on gastric emptying of low- and high-nutrient drinks in healthy young subjects: impact on glycaemia', in DIABETOLOGIA, SPRINGER, GERMANY, Berlin, Vol. 61, pp. S335 - S335, presented at 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), GERMANY, Berlin, 01 October 2018 - 05 October 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443556004057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Sheu A; Bliuc D; Eisman JA; Greenfield JR; White C; Center JR, 2018, 'FRACTURE IN TYPE 2 DIABETES CONFERS EXCESS MORTALITY', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, AUSTRALIA, Sydney, Vol. 30, pp. S92 - S92, presented at IOF-Regional 7th Asia-Pacific Osteoporosis Conference, AUSTRALIA, Sydney, 29 November 2018 - 01 December 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469495000151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Sheu A; Bliuc D; Eisman JA; Greenfield JR; White C; Center JR, 2018, 'VISCERAL FAT AND INSULIN RESISTANCE ARE ASSOCIATED WITH LOWER BONE TURNOVER', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, AUSTRALIA, Sydney, Vol. 30, pp. S93 - S93, presented at IOF-Regional 7th Asia-Pacific Osteoporosis Conference, AUSTRALIA, Sydney, 29 November 2018 - 01 December 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469495000153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Posters | 2017
    Chowdhury G; Smith F; MacDonald P; Carland J; Stocker S; Kumar S; Greenfield J; Williams K; Graham G; Day R, 2017, 'The Safety and Pharmacokinetics of Metformin in Heart Failure', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
    Conference Presentations | 2017
    Chowdhury G; Smith F; MacDonald P; Carland J; Stocker S; Kumar S; Greenfield J; Williams K; Graham G; Day R, 2017, 'The safety and pharmacokinetics of metformin in heart failure', presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
    Conference Abstracts | 2017
    Greenfield J, 2017, '"Year in" type 2 diabetes: Epidemiology, aetiology and treatment', in CLINICAL ENDOCRINOLOGY, WILEY, AUSTRALIA, Perth, Vol. 89, pp. 4 - 4, presented at Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), AUSTRALIA, Perth, 27 August 2017 - 30 August 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436537900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Isaacs M; Costin M; Barrett HL; Samaras K; Greenfield JR, 2017, 'Retrospective review of 64 patients with amiodarone-induced thyrotoxicosis', in CLINICAL ENDOCRINOLOGY, WILEY, AUSTRALIA, Perth, Vol. 89, pp. 46 - 47, presented at Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), AUSTRALIA, Perth, 27 August 2017 - 30 August 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436537900106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Reports | 2017
    Kumar SS; Graham GG; Smith FC; Furlong TJ; Greenfield JR; Stocker SS; Carland JE; Day RO, 2017, Could metformin be used in patients with advanced chronic kidney disease?, http://dx.doi.org/10.1111/dom.12806
    Conference Abstracts | 2017
    Milder TY; Greenfield J; Matthews G; Center J, 2017, 'Hypophosphataemic osteomalacia induced by tenofovir disoproxil fumarate', in CLINICAL ENDOCRINOLOGY, WILEY, AUSTRALIA, Perth, Vol. 89, pp. 70 - 70, presented at Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), AUSTRALIA, Perth, 27 August 2017 - 30 August 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436537900157&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Radhakutty A; Petersons CJ; Mangelsdorf BL; Drake SM; Thompson CH; Greenfield JR; White CP; Burt MG, 2017, 'Effect of prednisolone and hyperinsulinaemia on bone turnover in patients with inflammatory arthritis', in CLINICAL ENDOCRINOLOGY, WILEY, AUSTRALIA, Perth, Vol. 89, pp. 15 - 15, presented at Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), AUSTRALIA, Perth, 27 August 2017 - 30 August 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436537900030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Sheriff N; De Sousa S; Manzoor N; Toogood V; Greenfield J; Jones G; McCormack A, 2017, 'Chicken or the egg: Cortisol dysregulation is frequent but overt Cushing's syndrome is rare in an unselected type 2 diabetes population', in CLINICAL ENDOCRINOLOGY, WILEY, AUSTRALIA, Perth, Vol. 89, pp. 60 - 60, presented at Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), AUSTRALIA, Perth, 27 August 2017 - 30 August 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436537900136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2017
    Smith F; Furlong T; Greenfield J; Stocker S; Carland J; Graham G; Williams K; Day R, 2017, 'The Safety of Metformin in Haemodiafiltration', presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
    Conference Posters | 2017
    Smith F; Furlong T; Greenfield J; Stocker S; Carland J; Graham G; Williams K; Day R, 2017, 'The Safety of Metformin in Haemodiafiltration', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
    Reports | 2016
    Shrosbree J; Pokorny A; Stone E; Epstein R; Mccormack A; Greenfield JR, 2016, Ectopic Cushing syndrome due to neuroendocrine prostatic cancer, http://dx.doi.org/10.1111/imj.13063
    Conference Presentations | 2016
    Smith F; Kumar S; Furlong T; Gangaram S; Greenfield J; Stocker S; Carland J; Graham G; Williams K; Day R, 2016, 'Extraction of Metformin During Haemodiafiltration', presented at ASCEPT-MPGPCR, Melbourne, 27 November 2016 - 30 November 2016
    Conference Abstracts | 2015
    Chen DLT; Chisholm D; Brown R; Macefield V; Samocha-Bonet D; Greenfield J, 2015, 'Liver insulin sensitivity is linked with resting sympathetic nervous activity in non-diabetic obese men', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, Vol. 58, pp. S121 - S121, presented at 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 14 September 2015 - 18 September 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359820900241&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2015
    De Sousa SMC; Schofield L; Jones GRD; Greenfield JR; McCormack AI, 2015, 'Comparison of the insulin tolerance test against the glucagon stimulation and short Synacthen tests in patients with suspected hypopituitarism', in CLINICAL ENDOCRINOLOGY, WILEY, AUSTRALIA, Adelaide, Vol. 84, pp. 34 - 34, presented at Annual Scientific Meeting of the Endocrine-Society-of-Australia, AUSTRALIA, Adelaide, 23 August 2015 - 26 August 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000372310400094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Chen DLT; Samocha-Bonet D; Liess C; Poljak A; Xu A; Zhang J; Thoma C; Trenell M; Jenkins A; Milner B; Chisholm DC; Greenfield JR, 2014, 'Dual Insulin Resistance in Muscle and Liver, but Not a Single Site, Is Associated with Visceral and Liver Lipid Accumulation in Obesity', in Clinical Studies in Obesity: Endocrine Society, USA, presented at Endo, USA, 21 June 2014 - 24 June 2014
    Conference Abstracts | 2014
    Isaacs M; Brzozowska MM; Xu A; Greenfield J; Center J, 2014, 'Effects of bariatric surgery on adipokine profile over 12 months in humans', in Obesity Research & Clinical Practice, The Australian and New Zealand Obesity Society (ANZOS) annual meeting, presented at The Australian and New Zealand Obesity Society (ANZOS) annual meeting, http://dx.doi.org/10.1016/j.orcp.2014.10.092
    Reports | 2013
    Greenfield JR; Chisholm DJ, 2013, How Sweet It Is: Intestinal Sweet Taste Receptors in Type 2 Diabetes, http://dx.doi.org/10.2337/db13-1018
    Conference Presentations | 2013
    Greenfield JR; Samaras K; Campbell LV, 2013, 'Sugar-sweetened beverages, genetic risk, and obesity [1]', http://dx.doi.org/10.1056/NEJMc1213563
    Conference Papers | 2010
    Lee P; Greenfield JR; Fulham MJ; Ho KKY, 2010, 'Brown Adipose Tissue in Humans: Prevalence, Anthropometric and Metabolic Predictors.', in ENDOCRINE REVIEWS, ENDOCRINE SOC, CA, San Diego, presented at 92nd Meeting and Expo of the Endocrine Society (ENDO 2010), CA, San Diego, 19 June 2010 - 22 June 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281989401426&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2010
    Lee P; Zhao JT; Bova R; Gracie G; Freund J; Greenfield JR; Ho KKY, 2010, 'Cellular Characterisation of Human Brown Adipose Tissue Identified by Positron Emission Tomography.', in ENDOCRINE REVIEWS, ENDOCRINE SOC, CA, San Diego, presented at 92nd Meeting and Expo of the Endocrine Society (ENDO 2010), CA, San Diego, 19 June 2010 - 22 June 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281989402473&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2010
    Samocha-Bonet D; Turner N; Mori TA; Croft K; Viardot A; Tam CS; Greenfield JR; Campbell LV; Heilbronn LK, 2010, 'Short-Term Overfeeding and Moderate Weight Gain Induces Peripheral Insulin Resistance and Increases Systemic Oxidative Stress in Healthy Humans', in DIABETES, AMER DIABETES ASSOC, FL, Orlando, pp. A422 - A422, presented at 70th Annual Meeting of the American-Diabetes-Association, FL, Orlando, 25 June 2010 - 29 June 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000278844602211&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Viardot A; Samocha-Bonet D; Greenfield JR; Campbell LV; Heilbronn LK, 2009, 'Experimental weight gain in humans induces insulin resistance in absence of systemic or adipose tissue inflammation', in DIABETOLOGIA, SPRINGER, AUSTRIA, Vienna, pp. S74 - S74, presented at 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes, AUSTRIA, Vienna, 30 September 2009 - 02 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269262400165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2008
    Viardot AC; Samocha-Bonet D; Greenfield JR; Campbell LV; Heilbronn L, 2008, 'Experimental weight gain in humans induces insulin resistance in absence of systemic or adipose tissue inflammation', in Diabetologia, Springer, New York, NY, USA, pp. 164 - 165, presented at Diabetologia
    Conference Abstracts | 2005
    Meier C; Meinhardt U; Greenfield JR; Nguyen TV; de Winter J; Seibel MJ, 2005, 'Serum cathepsin K measurements: Repeatability, intra-subject and postprandial variability', in Bone, Elsevier Science Inc, Vol. 36, pp. S197 - S197
    Conference Abstracts | 2005
    Meinhardt U; Kraenzlin ME; Greenfield JR; Nguyen TV; Dunstan CR; Seibel MJ, 2005, 'Serum cathepsin K levels reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.', in JOURNAL OF BONE AND MINERAL RESEARCH, AMER SOC BONE & MINERAL RES, TN, Nashville, Vol. 20, pp. S222 - S223, presented at 27th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, TN, Nashville, 23 September 2005 - 27 September 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233503803009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2005
    Meinhardt UJ; Meier C; Nguyen TV; Greenfield JR; Dunstan CR; Kraenzlin C; Seibel MJ, 2005, 'Serum cathepsin K measurements: Repeatability, intra-subject and postprandial variability.', in JOURNAL OF BONE AND MINERAL RESEARCH, AMER SOC BONE & MINERAL RES, TN, Nashville, Vol. 20, pp. S223 - S223, presented at 27th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, TN, Nashville, 23 September 2005 - 27 September 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233503803011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2003
    Samaras K; Greenfield JR; Jenkins AB; Kelly PJ; Spector TD; Campbell LV, 2003, 'Gene-environment interactions influence relationships between alcohol and polyunsaturated fat intakes and central abdominal fat in healthy female twins.', in DIABETOLOGIA, SPRINGER-VERLAG, FRANCE, PARIS, pp. A227 - A227, presented at 18th Congress of the International-Diabetes-Federation, FRANCE, PARIS, 24 August 2003 - 29 August 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000185242100655&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

2023    Raven L and Greenfield JR. A phase 2, randomised, placebo-controlled trial of SGLT2 inhibition with empagliflozin on metabolic, renal and cardiac transplant recipients. Australian Diabetes Research Grant: $20,000.

2022    Humphreys S, James D, Greenfield JR (CIC), Wojtaszewski J. Mapping the beneficial effects of exercise in humans using personalised phosphoproteomics. NHMRC Ideas Grant, APP2011083: $1,348,941.

2022   Greenfield JR, Jabbour A, Hayward A, MacDonald P, Raven L Muir C. A phase 2, randomised, placebo-controlled trial of SGLT2 inhibition with empagliflozin on metabolic,renal and cardiac transplant patients. St. Vincent’s Clinic Foundation Sr Mary Bernice Packer Family Foundation Research Grant: $120,000.

2022   Perera C, Minoti A, Zhihong X, Falasca M, Goldstein D, Greenfield JR (CI5), Hardikar A. Innovation Grant: Early Detection with a focus on Rural and Regional areas. TheAustralian Pancreatic Cancer Foundation: $99,895.

2021    Greenfield JR, Patel S, Fourlanos S, Grey S, Phan T, Ma C. Elucidating the immune and metabolic phenotype of autoantibody negative diabetes in adults. St. Vincent’s Clinic Foundation Sr Mary Bernice Packer Family Foundation Research Grant: $120,000.

2020   Greenfield JR, Snaith J, Samocha-Bonet D, Holmes-Walker J, Girgis C. INTIMET INsulin resistance in Type 1 diabetes managed with METformin. St. Vincent’s Clinic Foundation Tancred Research Grant: $50,000.

2020    Apte M, Perera C, Chari S, Greenfield JR (CID), Xu Z, Wilson J, Pirola R. Pancreatic Cancer-Related Diabetes: Novel Role of Pancreatic Stellate Cells. NHMRC Ideas Grant, APP1185751: $486, 000.

2019   Greenfield JR, Snaith J, Holmes-Walker J, Girgis C, Samocha-Bonet. Phenotypic Characterisation of Insulin-Sensitive and Insulin-Resistant Adults with Type 1 Diabetes. Diabetes Australia Research Trust Millennium Grant (Type 1):  $150,000.

2019    Liu G, Morris M, Craig M, Greenfield JR, Vranes P. Smart point-of-care paper test strips towards prevention of type 2 diabetes. Biomedical Engineering Seed Fund, UNSW: $45,0817.

2019     Day R, Greenfield JR, Sevastos J, Stocker S, Samocha-Bonet D, Milder T. Vascular effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin in people with type 2 diabetes and chronic kidney disease. St Vincent’s Clinic Foundation SVPHS Ladies’ Committee Sister Mary Bernice Research Grant: $120,000.

2018    Greenfield JR, Samocha-Bonet D. Personalised Medicine in Prediabetes – Towards Preventing Diabetes in Individuals at Risk. St Vincent’s Clinic Foundation SVPHS Ladies’ Committee Sister Mary Bernice Research Grant: $100,000.

2017   Gregory L, Taylor J, Greenfield JR. Introducing a Dose Adjustment For Normal Eating program for type 1 diabetes. 2017 St Vincent’s Clinic Foundation Research Grant: $30,000.

2017  Day R, Macdonald P, Greenfield JR, Graham G, Stocker S, Carland J. The safety and pharmacokinetics of metformin in heart failure. 2017 St Vincent’s Clinic FoundationResearch Grant: $30,000.

2017   Day R, Carland JE, Stocker SL, Norris RLG, Greenfield JR. UNSW Research Infrastructure Scheme 2017: Supporting Collaborative Research. Installation of a Shimadzu Nexera X2 UHPLC in the Depart of Clinical Pharmacology: $78,431.

2016    Samocha-Bonet D, Greenfield JR. Body acid/base balance and insulin resistance in obesity. Diabetes Australia Research Trust: $60,000.

2016    Greenfield JR, Center JR. St. Vincent’s Clinic Foundation Tancred Research Grant: $50,000

2014    Greenfield JR, Samocha-Bonet D. Insulin-sensitive obesity: is it a sustained phenotype? Anonymous* Research Foundation (*at request of Foundation): $380,000

2013    Samocha-Bonet D, Greenfield JR, Meikle PJ, Coster ACF, Tonks K. The role of sphingolipids in insulin resistance - a follow up study in humans. Diabetes Australia Research Trust: $60,000

2012    McCormack AI, Greenfield JR. St. Vincent’s Clinic Foundation Tancred Grant: Insulin signalling pathway in cancer tissue of insulin-resistant, insulin-sensitive and type 2 diabetic humans: $66,000

2011    Greenfield JR, Swarbrick M, Lee P, Freund J, Macefield V, Dawood T. Is MC4R deficiency associated with alterations in sympathetic nervous system and brown adipose tissue activity in humans? St. Vincent’s Clinic Annual grant: $30,000

2010   Burt M, Greenfield JR, Slavotinek J, Thompson. Effect of acute and chronic glucocorticoids on carbohydrate metabolism in elderly subjects. Diabetes Australia Research Trust: $58,290

2010     Ho K, Lee P, Greenfield JR, Freund J, Bova R. Significance of brown fat in humans. St. Vincent’s Clinic Annual grant: $30,000

2010    Greenfield JR, Samoch-Bonet D, Campbell LV. St. Vincent’s Clinic Annual grant: $30,000.

2009    Greenfield JR (New Investigator, sole CIA), NHMRC Project Grant. Effect of oral glutamine on GLP-1 and insulin secretion and glycaemia in humans: $382,500

2009    Day RO, Kirkpatrick CM, Williams KM, Greenfield JR, Giacomini K, ARC Linkage Grant. $195,214

2008    James DJ, Greenfield JR. Diabetes Australia Millennium Grant (Type 2): Defining the insulin-signalling defect in human insulin resistance and type 2 diabetes: $150,000

2008    Greenfield JR, James DJ, Chisholm DJ. St. Vincent’s Clinic Foundation Tancred Grant: $50,000

2008    Greenfield JR, Samocha-Bonet D, Viardot A, Campbell LV. Pfizer Neuro Science Grant: $50,000

2008    Greenfield JR. Diabetes Australia Research Trust: $50,000 

2005    Greenfield JR. RACP Servier Cardiovascular Metabolic Fellowship: $20,000

2005    Greenfield JR. St. Vincent’s Clinic Foundation Travelling Fellowship: $10,000

2004    Greenfield JR, Chisholm DJ, Campbell LV. Cardiovascular Lipid Research Grant: $40,000

2001    Greenfield JR. NHMRC Travelling Award for Research Training Scholarship #209658: $10,000

2001    Greenfield JR. NHMRC Medical/Dental Award for Research Training (PhD) #152502

1999    Greenfield JR. Chisholm DJ. RT Hall Trust Grant

Select awards:

2020    University of NSW 2020 Arc Postgraduate Council Research Supervisor Award

2017    Ranji and Amara Wikramanayake Clinical Diabetes Award, Australia Diabetes Society 

2010    Don Chisholm Fellowship, Garvan Institute of Medical Research

2005    PhD Thesis Prize, Garvan Institute of Medical Research

1989-94 Inaugural Alumni Association Scholarship, University of New South Wales


 

Fields of research:  Diabetes, Obesity, Metabolism

Research interests: 

Our recent discoveries have identified a group of overweight and obese humans who appear to be at lower risk of diabetes and heart disease than other obese individuals. A major focus of our laboratory is to establish the factors that confer this metabolic protection and to devise a set of clinical criteria that will assist in their identification in clinical practice. The outcome of this research will expand our knowledge regarding the relative importance of metabolic abnormalities, such as abdominal and liver fat, on the development of insulin resistance and diabetes. We will find out what protects the overweight and obese people and whether they remain at lower risk of metabolic disease over long periods of time.

Another focus of our group is the identification of specific genetic defects that cause diabetes and obesity in humans. The conditions we are studying are monogenic or single-gene obesity disorders (including melanocortin 4 deficiency), lipodystrophies (partial and generalised) and monogenic diabetes (previously known as MODY - Maturity Onset Diabetes of the Young). Major improvement in insulin resistance after bariatric surgery in a lipodystrophy due to a novel gene has just been reported for the first time.

Other studies have established the effects of glutamine, an amino acid, on metabolism, both in isolation and in combination with a new diabetes medication. Glutamine appears to have a promising effect on glucose lowering in the post-meal state and may offer a simple, novel and effective treatment in type 2 diabetes. We are studying the effects on an alkaline diet on insulin sensitivity in humans, to determine whether there is any scientific evidence that this approach improves metabolic health.

We have undertaken collaborative studies with the Department of Clinical Pharmacology at St Vincent's Hospital to study the effects of metformin, particularly in relation to specific genetic variations in humans.

Our current focus is on investigating the potential benefits of type 2 diabetes medications (SGLT-2 inhibitors and GLP-1 receptor agonists) in individuals with type 1 diabetes, in order to reduce morbidity and cardiovascular mortality.